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Chapter 1 
General introduction 
Agricultural chemicals include not only agents that protect agricultural products from 
pathogens, insects and weeds, but also agents that regulate plant growth. They have 
contributed to a revolution in food production. However, they were produced by chemical 
industries and used by farmers without forethought of their substantial potential to harm the 
environment. Along with the increasing use of chemicals in agriculture, chemical 
contamination of food and of the environment has become a vast and enormously important 
worldwide problem. At the same time, however, agricultural chemicals are indispensable for 
the stable supply and quality control of agricultural products. 
As a category of agricultural chemicals, plant growth regulators are widely used in plant 
production to control plant size, leaf shedding, growth cessation and other characteristics 
(Geissbuehler et al., 1987). They are an effective way to create a uniform appearance for 
marketing purposes as well as for creating other characteristics that improve handling and 
shipping. In rice cultivation, the use of plant growth regulators to control plant height could 
reduce lodging, permit higher nitrogen application rates, and increase yields. Most nitrogen 
recommendations are based on an application rate that will produce the maximum yield. 
Lodging generally results in lower yield and grain quality. A plant shortener or stalk stiffener 
would be valuable for the rice industry (Eastin, 1983). Uniconazole (Izumi et al., 1984), 
paclobutrazol (Pulley and Davis, 1986) and inabenfide (Okatake, 1986) (Fig. 1-1) are highly 
effective at preventing lodging. However, they are chemically synthesized and perhaps 
persistent in the environment. 
A number of researches have been conducted to find new agricultural chemicals with low 
toxicity, low persistence, and high activity. Natural substances are believed to have the 
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N I 
--..:N 
Cl-<1 \~ ~N Cl 
~ N~N HO 
Uniconazole Paclobutrazol Inabenfide 
Fig. 1-1 Structures of retardants 
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advantage of low persistency in the environment; if they have high activity, they can be used 
in place of synthetic agricultural chemicals. In screening programs for agricultural chemicals, 
the quality and structural diversity of the compounds tested are also quite important. The 
exceptional biosynthetic capabilities of microorganisms suggest that the search for novel 
microbial metabolites possessing bioactivity against plant disease, insects, and weeds would 
be particularly valuable (Duke and Lydon, 1987, Cutler, 1984). Fungi produce structurally 
diverse secondary metabolites, most of which remain to be identified and tested for their 
bioactivities. These metabolites can be used for directly to control the height of the rice plant, 
and may also lead to the development of new plant growth retardants. Therefore, I chose fungi 
as a source of natural substances for this study. 
I tested the retardant activity of fungal metabolites with the microdrop bioassay. One 
known method to detect GAs was developed using dwarf rice (cv. Tanginbozu or cv. Waito C). 
Instead of dwarf rice, I used normal rice (cv. Koshihikari) to test the retardant activity of the 
fungal metabolites. The Koshihikari is a cultivar whose elongate stem gives it a tendency 
toward lodging. By this assay I can detect the retardation activity sensitively. In the course of 
screening in my laboratory, I found that cladospolide B and zygosporin D (Fig. 1-2) are plant 
growth retardants from Cladosporium tenuissimwn and Metarrhizium anisopliae, respectively 
(Fujii et al., 1995, 2000). C::H2 
H3C,, .. A .. ,,OH 
6~··,,oH 
0 
··•
1CH3 
0 
Cladospolide Zygosporin D 
Fig. 1-2 Structures of retardants reported previously in this laboratory 
The objective of this research is to find new natural plant growth retardants. For this 
purpose, I searched more than 300 soil samples collected in Tottori Prefecture, Japan, for 
fungi whose culture filtrates displayed plant growth retardant activity. I found a fungus that 
had this property, and from it I isolated three chlamydocin analogues as active metabolites. 
Chlamydocin is a bioactive cyclic tetrapeptide and is reported to inhibit HDAC activity 
(Brosch et al., 1995). 
My thesis is composed of five chapters. Chapter 2 deals with the identification of the 
fungus isolated from the soil in Tottori Prefecture, and the isolation and structural 
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determination of the active metabolites (1-3). In chapter 3, the plant growth retardant 
activities of compounds 1-3 are described. To investigate the structure-activity relationship in 
greater detail, I prepared and assayed six derivatives and two synthetic analogues. In chapter 4 
the results are discussed. In chapter 5, the mechanisms of retardation are discussed. To 
elucidate such mechanisms, the endogenous ABA and GA 1 levels in the rice plants treated 
with those retardants are determined. In addition, I investigated the inhibition of HDACs by 
those retardants to study the relationship between the retardation and inhibition of HDACs. 
References 
Brosch, G., Ransom, R., Lechner, T., Walton, J.D., Loidl, P., 1995. Inhibition of maize histone 
deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum. Plant Cell 7, 
1941-1950. 
Cutler, H. G., 1984. Biologically active natural compounds from fungi: templates for 
tomorrow's pesticide. Am. Chern. Soc. Symp. Ser. 257, 153. 
Duke, S. 0., Lydon, J., 1987. Herbicides from natural compounds. Weed Technol. 1, 122-128. 
Eastin, E.F., 1983. Plant growth regulators in rice. In: Nickell, L.G. (Ed.), Plant Growth 
Regulating Chemicals, Vol. II. CRC Press, Boca Raton, FL, pp. 150-160. 
Fujii, Y., Fukuda, A., Hamasaki, T., Ichimoto, I., Nakajima, H., 1995. Twelve-membered 
lactones produced by Cladosporiwn tenuissimum and the plant growth retardant activity 
of cladospolide B. Phytochemistry 40, 1443-1446. 
Fujii, Y., Tani, H., Ichinoe, M., Nakajima, H., 2000. Zygosporin D and two new cytochalasins 
produced by the fungus Metarrhiziwn anisopliae. J. Nat. Prod. 63, 132-135. 
Geissbuehler, H. Kerber, E., Mueller, U., 1987. Prospects for chemical plant growth 
regulation: An industrial viewpoint: An industrial viewpoint, In: Pinfield, J.R. (Ed.), In 
Plant Growth Regulators for Agricultural and Amenity Use. BCPC Monograph 36, 11-17. 
Izumi, K., Yamaguchi, I., Wada, A., Oshio, H., Takahashi, N., 1984. Effects of a new plant 
growth retardant (E)-1-( 4-chlorophenyl)-4, 4-dimethyl-2-( 1, 2, 4-triazol-1-yl)-1-penten-3-
ol (S-3307) on the growth and gibberellin content of rice plants. Plant Cell Physiol. 25, 
611-617. 
Okatake, S., 1986. Prevention of lodging in rice plant with chemical control. Nogyogijyutsu 
41, 55-59. 
Pulley, G.E., Davis, T.D., 1986. Effect of paclobutrazol on growth and interior performance of 
several foliage plant species. HortScience 21, 702. 
3 
Chapter 2 
Isolation and structure determination of compounds 1-3 from a soil fungus, 
Peniophora nuda 
2.1 Introduction 
Plant growth retardants play imp011ant roles in agriculture. In the cultivation of grains, they 
can reduce lodging by shortening the stem length and thus increase yield. During a screening-
based search for natural plant growth retardants in more than the 300 collections of soil fungi, 
l found a fungus whose culture filtrate could reduce the height of rice seedlings without 
causing either blotch or wilting. I describe here the identification of a soil fungus known as 
Peniophora nuda, and the isolation and structural elucidation of three active metabolites (1, 2 
and 3) (Fig. 2-I ). 
D-Pro 
Q·.,,,?O ~~N ~ v HN->:··' ~CH3 
L-Phe I( _N--l,O Q 0 H 
aib 1 R=OH 
2R=H 
3 R=OAc 
Fig. 2-I Structures of compounds 1, 2 and 3 
2.2 Results and discussion 
2.2.1 Identification of a soil fungus 
A fungus (Fig. 2-2), whose culture filtrate had the retardant activity, did not form spores in 
many trials, making identification of the fungus difficult. Eventually, it was determined to be 
Peniophora sp. on the basis of electron microscopy observations and its ISS rRNA gene 
sequence. Electron microscopy showed that this fungus has a Dolipore-parenthesome septum 
in its hyphae (Fig. 2-3), indicative that it belongs to the holobasidiomycetes (Khan and 
Kimbrough, I9S2). The sequence of its ISS rRNA gene (1737 bases) was determined (data 
not shown) and a BLAST similarity search of the sequence showed that Peniophora nuda is 
the most closely related fungus (97% similarity). 
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Fig. 2-2 Peniophora nuda grown on potato-dextrose-agar medium 24°C for 10 days 
Fig. 2-3 Dolipore-parenthesome septum 
2.2.2 Isolation of active metabolites 
The P nuda was grown on malt extract medium without shaking at 24°C for 14 days in the 
dark. Extraction of metabolites from the culture filtrate and purification by chromatography 
gave compounds 1, 2 and 3 in respective yields of 3.3, 0.42 and 0.07 mg/1 of medium. 
Compound 1 had the molecular formula C28H40N40 6 from its HREIMS, with a molecular 
ion peak at m/z 528.2955, and NMR spectroscopic data. TheIR spectrum of 1 showed 
absorption bands at 3454 cm·1 for hydroxyl and/or amide groups, at 1697 cm· 1 for a ketone 
carbonyl group, and at 1667cm· 1 for amide carbonyl groups. A ketone carbonyl carbon 
resonance appeared at 8 212.4 in its 13C NMR spectrum, and four amide carbonyl carbon 
resonances at 8 171.9, 172.8, 174.3 and 175.6. Acetylation of 1 gave a monoacetate, 
suggesting it has one hydroxyl group. Structural clarifications were based on 1H- 1H COSY, 
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HMQC and HMBC data. Analysis of the NMR spectral data (Table 2-1) for compound 1 
suggested that it was the same as chlamydocin analogue isolated from Verticillium 
coccosporum by Gupta et al. (1994). The repmted spectral data, however, were insufficient 
for unambiguous identification because the NMR data were recorded in C6D6 and the optical 
rotation was not described. I therefore collected NMR spectral data in C6D6 and found them 
identical to the reported data, indicative that compound 1 has the same structure and same 
relative stereochemistry as the reported analogue. To confirm the absolute stereochemistry of 
1, acid hydrolysis of the compound was carried out. HPLC analysis after derivatizing the 
hydrolyzate with ( + )-1-(9-fluorenyl) ethyl chloroformate (Hayashi and Sasagawa, 1993) 
showed that the phenylalanine derivative in the hydrolyzate had the same retention time as the 
L-phenylalanine derivative, evidence that the stereochemistry of the phenylalanine in 1 is L, 
the same as the reported configuration. Thus 1 was definitively identified as the same as the 
chlamydocin analogue reported by Gupta et al. (1994). 
Compound 2 was characterized as follows: it had the molecular formula C28H40N40 5 on the 
basis of its HREIMS data, which showed a molecular ion peak at m/z 512.300l.lts NMR 
spectral data were similar to those of 1, indicating that 2 is also a chlamydocin analogue. Its 
structure was clarified by comparing its NMR spectral data (Table 2-2) with those for 1. The 
carbon resonance (8 72.6) produced by an oxygenated methine carbon C-9 of aod, present in 
the 13C NMR spectrum of 1, was absent. Instead, there was a carbon resonance (8 35.9) due to 
a methylene carbon in the 13C NMR spectrum of 2. Fmthermore, its 'H NMR spectmm 
showed a two-proton quartet signal at 8 2.41 and a three-proton triplet signal at 8 1.05, whose 
signals were coupled. These findings indicate that compound 2 has a stmcture in which the 
hydroxyl at the C-9 of aod in compound 1 has been lost. Loss of chirality at the C-9 of aod 
changed the shape of the proton signal (H-7 of aod) from the AB type triplet in compound 1 to 
a simple triplet in compound 2. The amino acid sequence of compound 2 was confirmed from 
the HMBC correlations between the NH of aod and C-1 of Pro, between the NH of aib and C-
1 of aod, and between the NH of Phe and C-1 of aib. NOE data (Fig. 2-4) support this 
sequence. The fact that the NOE data for compound 2 are almost the same as those reported 
for compound 1 suggests that the compounds have the same relative stereochemistry. 
Compound 2 has been obtained from chlamydocin by chemical conversion (Closse and 
Huguenin, 1974), but there were insufficient spectroscopic data for unequivocal 
characterization. Ours is the first report of compound 2 as a natural product and of its full 
spectroscopic data. 
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Table 2-1 NMR data CH, 500 MHz and 13C, 125 MHz) for compound 1 in CDC13 
Unit position 1 
be {)H 
aho 1 174.3 
2 54.3 4.18 (1H, ddd, 10.2, 7.8, 7.6) 
3 28.74 1.64 (1H, m) 
1.79 (lH, m) 
4 25.2 1.33 (2H, m) 
5 28.69 1.29 (2H, m) 
6 23.2 1.63 (2H, m) 
7 37.2 2.41 (lH, ddd, 17.3, 7.3, 7.3) 
2.50 (lH, ddd, 17.3, 7.3, 7.3) 
8 212.4 
9 72.6 4.23 (lH, q, 7.1) 
10 19.8 1.37 (3H, d, 7.1) 
NH 7.13 (lH, d, 10.2) 
aib 1 175.6 
2 58.8 
3 23.5 1.77 (3H, s) 
4 26.4 1.34 (3H, s) 
NH 6.00 (IH, s) 
Phe 1 172.8 
2 53.4 5.15 (lH, ddd, 10.2, 10.2, 5.8) 
3 35.8 2.95 (lH, dd, 13.6, 5.8) 
3.25 (lH, dd, 13.6, 10.2) 
4 137.0 
5,9 129.0 7.22 (2H, m) 
6,8 128.6 7.29 (2H, m) 
7 126.7 7.20 (lH, m) 
NH 7.51 (lH, d, 10.2) 
Pro 1 171.9 
2 57.7 4.65 (lH, dd, 7.8, 2.2) 
3 24.7 1.74 (lH, m) 
2.31 (IH, m) 
4 25.0 1.75 (IH, m) 
2.16 (lH, 1n) 
5 46.9 3.21 (lH, ddd, 10.2, 7.3, 7.3) 
3.86 (lH, ddd, 10.2, 9.0, 4.9) 
1H NMR data represent chemical shift, multiplicity (J in Hz). 
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Table 2-2 NMR data CH, 500 MHz and 13C, 125 MHz) for compound 2 in CDC13 
Unit position 2 
Oc OH 
aod 1 174.4 
2 54.3 4.18 (lH, ddd, 10.3, 7.6, 7.6) 
3 28.8 1.56 (lH, m) 
1.78 (lH, m) 
4 25.3 1.28 (2H, m) 
5 28.69 1.28 (2H, m) 
6 23.6 1.56 (2H, m) 
7 42.1 2.40 (lH, t, 7.6) 
8 211.7 
9 35.9 2.41 (2H, q, 7.3) 
10 7.8 1.05 (3H, d, 7.3) 
NH 7.09 (lH, d, 10.3) 
aih 1 175.6 
2 58.8 
3 23.5 1.77 (3H, s) 
4 26.4 1.34 (3H, s) 
NH 6.00 (1H, s) 
Phe I 172.8 
2 53.4 5.15 (lH, ddd, 10.2, 10.2, 5.8) 
3 35.8 2.95 (lH, dd, 13.6, 5.8) 
3.26 (lH, dd, 13.6, 10.2) 
4 137.0 
5,9 129.0 7.22 (2H, m) 
6,8 128.6 7.28 (2H, m) 
7 126.7 7.19 (lH, m) 
NH 7.51 (lH, d, 10.2) 
Pro 1 171.8 
2 57.8 4.66 (lH, dd, 7.8, 2.2) 
3 24.7 1.78 (lH, m) 
2.31 (lH, m) 
4 25.0 1.78 (lH, m) 
2.17 (lH, m) 
5 47.0 3.22 (1H, ddd, 10.2, 7.3, 7.3) 
3.86 (lH, ddd, 10.2, 8.5, 5.1) 
'H NMR data represent chemical shift, multiplicity (J in Hz). 
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~O<;o) NH ~® CH3 0 
Fig. 2-4 Key NOE correlations in compound 2 
The structure of compound 3 was determined as follows: on the basis of its HREIMS, 
which showed a molecular ion peak at m/z 570.3035, and its NMR spectral data, this 
compound has the molecular formula C30H42N,p7• The NMR spectmm is similar to that of 1, 
evidence that 3 also is a chlamydocin analogue. Its structure was established by comparing 
its NMR spectral data (Table 2-3) with those for 1 and by chemical conversion. Two new 
additional carbon resonances (0 170.4 and 20.7), not observed in the 13C NMR spectrum of 1, 
were present in the 13C NMR spectrum of 3, and an additional new three proton singlet signals 
appeared at 0 2.15 in its 1 H NMR spectrum. These findings indicate there is an additional 
acetyl group in 3. Furthermore, the hydroxyl methane proton signal produced by the H-9 of 
aao was shifted down field (0 4.23 in the 1H NMR spectrum of 1 to 0 5.08 in that of 3), 
indicative that the acetoxyl group attached to the C-9 of aao. To verify this, compound 1 was 
acetylated by the usual method. The resulting product was identical in all respects to 3. 
Compound 3, therefore, is a new compound, never before reported. 
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Table 2-3 NMR data CH, 500 MHz and 13C, 125 MHz) for compound 3 in CDC13 
Unit position 3 
Oc OH 
aao 1 174.4 
2 54.3 4.18 (lH, ddd, 10.2, 7.6, 7.6) 
3 28.74 1.64 (lH, m) 
1.79 (lH, m) 
4 25.2 1.29 (2H, m) 
5 28.62 1.29 (2H, m) 
6 22.9 1.56 (2H, m) 
7 37.9 2.41 (lH, ddd, 17.6, 7.3, 7.3) 
2.51 (lH, ddd, 17.6, 7.3, 7.3) 
8 207.6 
9 74.6 5.08 (lH, q, 7.1) 
10 16.1 1.39 (3H, d, 7.1) 
NH 7.08 (lH, d, 10.2) 
CH3CO 170.4 
CH3CO 20.7 2.15 (3H, s) 
aib 1 175.6 
2 58.8 
3 23.5 1.77 (3H, s) 
4 26.4 1.34 (3H, s) 
NH 6.00 (1H, s) 
Phe 1 172.8 
2 53.4 5.15 (lH, ddd, 10.2, 10.2, 5.8) 
3 35.8 2.95 (lH, dd, 13.6, 5.8) 
3.26 (lH, dd, 13.6, 10.0) 
4 137.0 
5,9 129.0 7.22 (2H, In) 
6,8 128.6 7.29 (2H, In) 
7 126.7 7.20 (lH, m) 
NH 7.51 (lH, d, 10.0) 
Pro 1 171.9 
2 57.7 4.66 (lH, dd, 8.0, 2.7) 
3 24.7 1.74 (lH, In) 
2.31 (1H, m) 
4 25.0 1.75 (lH, m) 
2.16(1H,In) 
5.9 3.22 (lH, ddd, 10.2, 7.6, 7.6) 
3.86 (lH, ddd, 10.2, 8.3, 4.9) 
1H NMR data represent chemical shift, multiplicity (J in Hz). 
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2.3 Experimental 
2.3.1 General experimental procedures 
Optical rotation was measured with a Horiba SEPA-200 polarimeter. UV spectra were 
recorded with a Hitachi U-2001 spectrophotometer, and IR spectra with a JASCO FT/IR 7000 
spectrometer. NMR spectra were measured with a JEOL Lambda 400 NMR spectrometer. 
Chemical shifts were referenced to CDC13 (8H 7.26, be 77.0). Mass spectra were obtained with 
a JEOL AX505HA spectrometer (direct probe, 70 e V). HPLC was carried out with a Cosmosil 
5C 18-AR column (Nacalai Tesque, 10 x 250 mm), a flow rate of 1.0 ml/min, and detection at 
220 nm. Daisogel IR-60 was used for silica gel column chromatography. 
2.3.2 Fungal material 
A fungal isolate, obtained from soil sample collected in Tottori prefecture, Japan was found 
to be very close to Peniophora nuda based on electron microscopy observations and the 
sequence of its ISS rRNA gene: for the electron microscopy study the fungus was grown on 
PDA medium at 25°C for 7 days. Sections prepared according to the procedure repmted (Suh 
et al., 1993) were observed with a JEOL JEM-1010 transmission electron micromascopic at 
100 kV. For analysis of the 18S rRNA sequence, the isolate was grown in YM medium (0.3% 
yeast extract, 0.3% malt extract, 0.5% peptone, 1% glucose; pH 5.6) at 25°C for three days 
with shaking. Mycelia were collected by centrifugation, freeze-dried, and disrupted in liq. N2. 
Genomic DNA was obtained with a Dneasy Plant Mini Kit (QIAGEN GmbH, Hilden, 
Germany). The PCR used genomic DNA as the template and NS 1 and NS8 (White et al., 
1990) as the PCR primers. Amplification conditions were 94°C for 1 min, followed by 30 
cycles of94oC for 1 min, 52°C for 30 s, 72°C for 2 min, and lastly 72°C for 2 min. PCR 
products were purified with a QIA quick PCR purification kit (QIAGEN GmbH, Hilden, 
Germany) and directly sequenced. NS1-8 were the sequencing primers (White et al., 1990). 
All the sequencing reactions were done with a Perkin-Elmer BigDye Terminator Kit, and the 
sequence determination with a Perkin-Elmer ABI PRISM 377 sequencer. 
2.3.3 Fermentation and extraction 
The fungus was grown without shaking at 24oC for 14 days in the dark in 500 ml conical 
flasks (100) containing liquid medium (200 ml/flask) composed of glucose (30 g/1), peptone 
(3 g/1), the extract from 50 g/1 of malt, and H20. Metabolites were extracted from the culture 
filtrate with EtOAc (3 x 10 1) after adjusting the pH to 2.0 with 6 M HCI. The EtOAc solution 
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was washed with 1M NaHC03 (2 x 0.5 volume), dehydrated over Na2S04 and concentrated to 
dryness for a residue ( 1.6 g). 
2.3.4 Purification 
The residue (1.6 g) was subjected to silica gel column chromatography (Daiso gel IR-60, 
16 x 230 mm), with 200 ml ( 40 ml x 5) each of 30, 40 and 60% acetone in n-hexane as eluant. 
The first fraction (143 mg), eluted with 40% acetone inn-hexane, was further purified by 
Sephadex LH-20 column chromatography (20 x 370 mm, MeOH). Five milliliter portions of 
the eluate were collected. Fraction 18 was dried by evaporation, giving 1 as a colorless oil (66 
mg). The third fraction (48 mg), eluted with 30% acetone inn-hexane and purified by HPLC, 
gave 2 as a colorless oil (8.4 mg, Rt 30.7 min). The forth fraction (39 mg), eluted with 30% 
acetone inn-hexane and purified by HPLC gave 3 as a colorless oil (1.5 mg, Rt 26.9 min). 
2.3.5 Compound 1 
[a] 250 -51 ° (c 0.1 0; EtOH). UV Amax nm (log£): 237 (3.58), 205 (4.26). IR vmax (film) cm-1: 
3454, 3288, 1697, 1667, 1622, 1528. 1H NMR and 13C NMR data: see Table 2-1. 1H- 13C 
HMBC correlations: aho H-2/aho C-1, aho C-3; aho H-3/aho C-4; aho H-4/aho C-3; aho H-
5/aho C-3; aho H-6/aho C-4, aho C-7; aho H-7/aho C-5, aho C-6, aho C-8; aho H-9/aho C-8, 
aho C-10; aho H-10/aho C-8, aho C-9; aib H-3/aib C-1, aib C-2, aib C-4; aib H-4/ aib C-1, aib 
C-2, aib C-3; aib NH/ aib C-2, aib C-3, aho C-1; Phe H-2/Phe C-1; Phe H-3/Phe C-1, Phe C-2, 
Phe C-4, Phe C-5, 9; Phe H-5,9/ Phe C-3; Pro H-2/Pro C-3, Pro C-4, Pro C-5; Pro H-3/Pro C-
1, Pro C-5; Pro H-5/Pro C-3, Pro C-4. ElMS m/z (rei. int.): 528 [Mt (26), 498 (8), 485 (20), 
471 (27), 428 (50), 426 (15), 409 (28), 343 (7), 330 (23), 314 (15), 269 (14), 229 (26), 219 
(10), 172 (14), 120 (37), 70 (100), 58 (66). HREIMS m/z: 528.2955 (calc. for C28H40N40 6, 
528.2948). 
2.3.6 Compound 2 
[af50 -55.6o (c 0.36; EtOH). UV Amax nm (log£): 237 (3.56), 205 (4.02). IR Vmax (film) 
cm- 1: 3453, 3310, 1692, 1667, 1628, 1530. 1H NMR and 13C NMR data: see Table 2-2. 1H- 13C 
HMBC correlations: aod H-2/aod C-1, aod C-3, Pro C-1; aod H-7/aod C-5; aod H-9/aod C-8; 
aod H-10/aod C-8; aod NH/Pro C-1; aib H-3/aib C-1, aib C-2; aib H-4/ aib C-1, aib C-2; aib 
NH/ aib C-3, aib C-4, aod C-1; Phe H-2/Phe C-1, aib C-1; Phe H-3/Phe C-1, Phe C-2; Phe 
NH/aib C-1; Pro H-2/Pro C-1, Pro C-4; Pro H-5/Pro C-4. ElMS mlz (rei. int.): 512 [Mt (16), 
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456 (14), 455 (16), 413 (13), 412 (44), 400 (11), 393 (22), 315 (18), 314 (51), 253 (22), 252 
(11), 229 (26), 201 (10), 156 (21), 131 (12), 120 (37), 91 (10), 70 (100), 58 (59), 57(24). 
HREIMS m/z: 512.3001 (calc. for C28H-1oN40 5, 512.2999). 
2.3.7 Compound 3 
[af50 -45.T (c 0.21; EtOH). UV Amax nm (log E): 237 (3.52), 211 (4.00). IR vmax (film) 
cm-1: 3456, 1705, 1690, 1456, 1032. 1H NMR and 13C NMR data: see Table 2-3. 1H- 13C 
HMBC correlations: aao H-2/aao C-1, aao C-3; aao H-4/aao C-3, aao C-4; aao H-5/aao C-4; 
aao H-6/aao C-4; aao H-7/aao C-5, aao C-6, aao C-8; aao H-9/aao C-8, aao C-10, aao CH3CO; 
aao H-10/ aao C-8, aao C-9; aao NH/Pro C-1; aao CH3CO/aao CH,CO; aib H-3/ aib C-1, aib 
C-2, aib C-4; aib H-4/ aib C-1, aib C-2, aib C-3: aib NH/ aib C-2, aib C-3, aib C-4, aao C-1; 
Phe H-2/Phe C-1, Phe C-3; Phe H-3/Phe C-1, Phe C-2, Phe C-4, Phe C-5,9; Phe H-5,9/ Phe 
C-3, Phe C-6,8, Phe C-7; Phe H-6,8/Phe C-4; Phe H-7/Phe C-5,9, Phe C-6,8; Phe NH/aib C-1; 
Pro H-2/Pro C-3, Pro C-4, Pro C-5; Pro H-3/Pro C-1; Pro H-5/Pro C-3, Pro C-4. ElMS mlz 
(rel. int.): 570 [Mt (24), 514 (20), 513 (29), 512 (13), 470 (47), 451 (26), 412 (18), 372 (43), 
314 (31), 311 (19), 310 (12), 229 (28), 214 (20), 120 (34), 70 (100), 58 (55). HREIMS mlz: 
570.3035 (calc. for C30H42N40 7, 570.3054). 
2.3.8 Acetylation of compound 1 
Compound 1 (9.5 mg) was treated overnight with 1 ml of acetic anhydride and 0.5 ml of 
pyridine. The product was purified by HPLC, giving compound 3 (8.8 mg). 
2.3.9 Amino acid analysis 
Compound 1 (0.6 mg) was hydrolysed in 0.12 ml of 6 M HCl at 110°C for 20 h. The 
reaction mixture was dried by evaporation and dissolved in 50 1-11 of 0.1 M borate buffer (pH 
9.0). Ten microliters of CH3CN and 2 1-11 of ( + )-1-(9-fluorenyl) ethyl chloroformate (Aldrich, 
18 mM in acetone) were added to 10 1-11 of the hydrolysate solution, after which the mixture 
was kept at 50oC for 15 min. The reaction was terminated by adding 25 1-11 of 100 mM cysteic 
acid in 0.1 M borate buffer (pH 9.0). Before HPLC analysis, the reaction mixture was diluted 
with 153!-11 of0.1 M NaOAc buffer (pH 4.0) (Hayasaki and Sasagawa, 1993). Analytical 
HPLC employed a Shim pack CLC-C8 (Shimazu, 6.0 x 150 mm) column. Delivertives were 
detected with a Shimazu RF 550 fluorescence detector (excitation: 260 nm; emission; 315 
nm). Two solvents were used; solvent A consisting of THF-NaOAc buffer (pH 4.0) (25:75, 
13 
v/v) and solvent B consisting ofTHF-NaOAc buffer (pH 5.1) (50:50, v/v). Gradient elution 
conditions were 0-25 min, 0-60% B; 25-80 min, 60% B; 80-90 min, 60-100% B; 90-95 min, 
100% B; 95-100 min, 100-0% B. The flow rate was 0.8 ml/min. Under these conditions the Rr 
of D-phenylalanine derivative was 81.4 min and that of the L-form 85.6 min. 
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Chapter 3 
Plant growth-retardant activity of compounds 1-3 
3.1 Introduction 
In previous chapter the structures of compounds 1-3 were shown. These metabolites have 
same framework as chlamydocin, but differ on the side chain. I describe here the plant 
growth-retardant activity of compounds 1-3, and the important parts of their structure. 
To test the retardant activity I used the microdrop bioassay (Murakami, 1968). The method 
was developed for the detection of GAs using dwarf rice (cv. Tanginbozu and cv. Waito C). I 
used this to test the retardant activity of fungal metabolites using normal rice ( cv. Koshihikari). 
The Koshihikari is a cultivar susceptible to lodging due to its elongated stem. By this assay I 
can detect the retardation activity sensitively. 
3.2 Results and discussion 
Plant growth-retardant activities for compounds 1-3 in a microdrop bioassay of rice 
seedlings are shown in Table 3-1 and Fig. 3-1. Administration of 10 nmol/plant of 1 or 2 
reduced the second leaf sheath of the treated plants, respectively to 73 and 71% of the value 
for the water control. The same amount of 3 produced 83% growth of the second leaf sheath 
in the treated as compared to control plants. Interestingly, compound 2 was more active than 3 
as active as 1. This suggests that the hydroxyl group at the C-9 of aho in 1 is not important for 
plant growth retardation and that the acetoxyl group at the C-9 of aao in 3 reduced activity. 
These data indicated that the hydroxyl at the C-9 of aho is not essential for the retardant 
activity, and thus the ketone function at the C-8 of aho is important. 
Cyclic tetrapeptides, which have both proline and an adjacent novel amino acid, aeo, 
include Cyl-2 from Cylindrocladium scoparium (Takayama et al., 1984), chlamydocin from 
Diheterospora chlamydosporia (Closse and Huguenin, 1974), and HC toxin from 
Helminthosporium carbonum (Walton et al., 1982), all of which are reported to have 
phytotoxic activity. A chlamydocin analogue that has aho instead of aeo has phytotoxic 
activity (Gupta et al., 1994). This means that the phtyotoxic activity is not produced by 
epoxide function of aeo. My present findings show that the 9-hydroxyl of aho is not essential 
for the retardant activity, and thus the 9-hydroxyl of aho may also not be essential for 
phytotoxicity. 
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Table 3-1 Effects of compounds 1-3 on second leaf sheath length of rice ( Oryza sativa L., cv. 
Koshihikari) seedlings 
Amount 
(nmol/plant) 
0 
0.3 
3 
10 
30 
Second leaf sheath length 
1 
R=OH 
100 (49.2 mm) 
94.5 ± 2.1 
81.6 ± 1.3 
78.3 ± 1.4 
73.0 ± 1.4 
57.6 ± 3.0 
2 
R=H 
100 (49.2 mm) 
95.3 ± 2.9 
84.8 ± 3.2 
79.2 ± 3.5 
71.0 ± 3.2 
59.6 ± 5.2 
3 
R=OAc 
100 ( 46.8 mm) 
100.0 ± 4.9 
100.4 ± 6.3 
94.0 ± 1.8 
82.9 ± 3.1 
79.1±3.1 
Values are presented as percentage of the control. Data are mean± standard error (n = 5) 
0 .. 0 N .,,~ 
u:G HN 13 0 -Y<,,~CH N~'"' 0 3 0 H O 
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Fig. 3-1 Effects of compounds 1-3 on rice ( Oryza sativa L., cv. Koshihikari) seedlings 
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3.3 Experimental 
3.3.1 Biological assays 
Compounds 1-3 were evaluated for their ability to retard the growth of rice plants. Rice 
seeds ( Oryza sativa L., cv. Koshihikari) were soaked in H70 for 48 hat 28oC under 
fluorescent light. Sets of six germinated seeds were planted on 1% agar medium in 30 ml 
beakers then incubated for 48 h under continuous light. A 1 111 drop of 50% aq. MeOH 
containing a certain amount of the test compound was placed between the shoot and first leaf 
of each seedling. After incuvation for 72 h under continuous light, the length of the second 
leaf sheath of the seedling was measured. 
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Chapter 4 
Synthesis of test compounds and their growth-retardant activities 
4.1 Introduction 
In previous chapter, the structure-activity relationship of 1 indicated that the hydroxyl at the 
C-9 of aho is not important, but the ketone function at the C-8 of aho is important for the 
retardant activity. I therefore investigated the structure-activity relationship of 1 in more detail. 
I describe here the preparation of six derivatives (4-9) and two synthetic analogues (10 and 
11) (Fig. 4-1 ), and their plant growth-retardant activities. 
Q···,,y-0 
~HN R ~,,, -;><NXo 
0 H 
OH 
8 : R=~CH3 1 
0 
OH 
R=~CH3 4 
OHOH 
R=~CH3 5 
OH 
R=~CH3 9 
R=~cHO 6 
R=~cH20H 7 
R=~~CH3 8 
R=~CH3 11 
R=Y"'cH3 10 
Fig. 4-1 Structures of compounds 1 and 4-11 
4.2 Results and discussion 
4.2.1 Preparation of test compounds 
Compounds 4-8 were prepared from 1, the major metabolite of the fungus, as shown in Fig. 
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4-2. The stereochemistry of the 8-hydroxyl of 4 and S was determined as follows. Compounds 
4 and S were treated with 2, 2-dimethoxypropane and p-toluenesulfonic acid to afford the 
corresponding acetonides, 4a and Sa. In the NOE experiments, irradiation of the H-8 of 4a 
enhanced the H -9 me thine signal, while irradiation of the H -8 of Sa enhanced the H -10 
methyl signal. These results revealed that the configuration of the 8-hydroxyl of 4 is Rand 
that of Sis S. Compound 9 was prepared from 2 by chemical conversion as shown in Fig. 4-2. 
Compounds 10 and 11 were synthesized according to the procedure reported by Pastuszak et 
al. ( 1982). The linear sequence was synthesized by a two-plus-two strategy as shown in Fig. 
4-3. These prepared compounds were checked by ElMS, and 1H and 13C NMR. 
OH 
R= ~CH3 Q·.,,f'O 
1 0 ~HN R 
l i OH CH3 ~~Xo 
R= ~~iii R= !~o 0 H ~ CH3-
4 OH 4a o+cH3 
+ 
H3C 
OH CH3 
R= $ = iii R= ~~',,·~o (~~~CH3-
5 OH 5 0--/-CH3 
l ii 
a H3C 
R= ~~CHO iv R= ~~8 v ~~CH3 - - R= 
6 6aV 8 
l i 
R= ~CH20H 
7 
R= ~ iv R= ~ v R- ~CH3 CH3- CH3- -
0 v 
2 2a 9 
Fig. 4-2 Preparation of compounds 4-9, Reagents and conditions: i, NaBH4, MeOH; ii, 
Nal04, aq. MeOH; iii, 2, 2-dimethoxypropane, p-toluenesulfonic acid; iv, 1, 3-propanedithiol, 
boron trifluoride-diethyl ether complex, CH2Cl2; v, Raney Ni (W-2), Dioxane, reflux. 
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Boc-L-aba 
Boc-L-nle 
Boc 
Boc 
Boc 
Boc 
Boc 
TFA·H 
Cyclo 
HCl· a-ai b-OMe 
I OMe 
11 OH 
Boc-L-Phe HCl·D-Pro-0 Me 
Boc 
I OMe 
TFA·H lll OMe 
IV 
OMe 
11 OH 
v 
OSu 
Ill OSu 
VI ) 10, 11 
Fig. 4-3 Synthesis of compounds 1Q and 11. Reagents: i, EEDQ; ii, NaOH; iii, TFA; iv, 
triethylamine, HOBt, DCC; v, HOSu, DCC; vi, pyridine. 
4.2.2 Plant growth-retardant activities 
Plant growth-retardant activities for compounds 1 and 4-11 were determined with a 
microdrop bioassay using rice (cv. Koshihikari) seedlings (Table 4-1). The test compounds 
were applied to the rice seedlings at the dose of 30 nmol/plant. Compounds 1, 4 and 5 reduced 
the length of the second leaf sheath to be 58, 78 and 69% of the control, respectively. In the 
rice seedlings treated with 6 and 7, the lengths of the second leaf sheaths were 51 and 67% of 
the control, respectively. These results indicated that the 8-oxo in aho and aoa moieties is 
important, but not essential for the retardant activity. Compound 5 was a little more active 
than 4, indicating that a small structural change, such as a change of the stereochemistry of 
only one carbon atom in the molecule, influences the retardant activity. Compound 9 
completely lost its retardant activity. This result suggested that all of the compounds that have 
a chlamydocin framework need the oxygen atom at the C-8 position of the ada moiety to 
exhibit their retardant activity. Surprisingly, compound 8 retained its retardant activity despite 
the absence of the oxygen atom at the C-8 position. Actually, compound 8 reduced the length 
of the second leaf sheath to be 70% of the control. Compounds 10 and 11 almost lost their 
retardant activity. The retention of retardant activity in compound 8 and the loss of the activity 
in compounds 9, 10 and 11 revealed that the length of the alkyl side chain in the compounds 
with no functionalities in the side chain is specific for the retardant activity. Compound 6 was 
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the most active among the compounds tested, presumably due to the additive effect of these 
two types of retardation. It is noteworthy that in the rice plant treated with 8 the shoots were 
remarkably curved (Fig. 4-4) compared with the control and with that treated with compound 
1. These phenomena suggested that the retardation mechanism of 8 is different from that of 1. 
Table 4-1 Effects of compounds 1 and 4-11 (30 nmol/plant) on second leaf sheath length of 
rice ( Oryza sativa L., cv. Koshihikari) seedlings 
Compound 
1 
4 
5 
6 
7 
8 
9 
10 
11 
R 
(CH2) 5COCH(R-OH)CH3 
( CH2) 5CH(R -OH)CH(R -OH)CH3 
(CH2) 5CH(S-OH)CH(R -OH)CH3 
(CH?),CHO 
(CH?),CH?OH 
- . -
(CH?),CH, 
(CH2) 7CH3 
CH2CH3 
(CH2) 3CH3 
Second leaf sheath length 
57.6 ± 3.0 
78.1 ± 2.0 
68.8 ± 1.5 
51.1±1.7 
67.5 ± 1.9 
69.5 ± 3.3 
97.3 ± 1.9 
91.6 ± 2.7 
90.6 ± 3.8 
Values are presented as percentage of the control. Data are mean ± standard error (n=5) 
Q-.,,~ro 
~HN R 
v HN~~Xo 
0 H 
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Fig. 4-4 Effect of compound 8 on rice ( Oryza sativa L., cv. Koshihikari) seedlings 
4.3 Experimental 
4.3.1 General experimental procedures 
Optical rotation was measured with a Horiba SEPA-200 polarimeter. UV spectra were 
recorded with a Hitachi U-2001 spectrophotometer. NMR spectra were measured with a JEOL 
JNM-ECP 500 NMR spectrometer. Chemical shifts were referenced to CDC13 (8H 7.26, De 
77 .0). Mass spectra were obtained with a JEOL AX505HA spectrometer (direct probe). 
Glycerol was the matrix used for FABMS. In ElMS the ionization voltage was 70 eV. In 
CIMS the reaction gas was iso-butane. HPLC was carried out with a Cosmosil 5C18-AR 
column (Nacalai Tesque, 10 x 250 mm), a flow rate of 1.0 ml/min, and detection at 220 nm. 
Daisogel IR-60 was used for silica gel column chromatography and Merck Kieselgel 60 F254 
forTLC. 
4.3.2 Compounds 4 and 5 
A soln of 1 (25.6 mg, 0.048 mmol) and NaBH4 (3.0 mg, 0.072 mmol) in dry MeOH (1.0 
ml) was stirred for 15 min at room temp. The reaction mixture was diluted with 15 ml of brine 
(pH 2.0 with 6 M HCl) , and the products were extracted with EtOAc (15 ml x 3). The EtOAc 
extract was dried over Na2S04 and evaporated in vacuo. The residue was purified by HPLC 
(70% MeOH) to give 4 (8.0 mg, 0.015 mmol, 31%, R1 19.2 min) and 5 (11.5 mg, 0.022 mmol, 
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46%, Rt 20.5 min) as colorless oils. 4: [a] 25 0 -49° (c 0.10; EtOH). UV Amax nm (log E): 236 
(3.54), 213 (3.91). 1H NMR (500 MHz, CDC13): ada o 1.15 (3H, d, J = 6.5 Hz, H-10), 1.25-
1.84 (IOH, m, H-3-7), 3.60 (IH, 1n, H-8), 3.78 (IH, dq, J = 3.5, 6.5, H-9), 4.19 (lH, ddd, J = 
7.6, 7.8, 10.1 Hz, H-2), 7.11 (lH, d, J = 10.1 Hz, NH), aib o 1.34 (3H, s, H-4), 1.77 (3H, s, H-
3), 5.97 (IH, s, NH), Phe o 2.95 (IH, dd, J = 5.8, 13.5 Hz, H-3), 3.26 (lH, dd, J = 10.1, 13.5 
Hz, H-3), 5.16 (IH, ddd, J = 5.8, 10.1, 10.1 Hz, H-2), 7.19-7.29 (5H, m, H-5-9), 7.51 (IH, d, J 
= 10.1 Hz, NH), Pro 0 1.25-1.84 (2H, m, H-3 and 4), 2.14-2.34 (2H, 1n, H-3 and 4), 3.22 (lH, 
ddd, J = 7.6, 7.6, 10.1 Hz, H-5), 3.86 (IH, ddd, J = 4.4, 8.3, 10.1 Hz, H-5), 4.66 (IH, dd, J = 
2.3, 8.1 Hz, H-2). 13C NMR (125 MHz, CDC13): o 16.7, 23.6, 24.7, 25.0, 25.3, 25.6, 26.5, 28.8, 
29.1, 31.5, 35.8, 47.0, 53.4, 54.4, 57.8, 58.8, 70.4, 74.8, 126.7, 128.6, 129.0, 137.0, 171.9, 
172.8, 174.4, 175.6. ElMS mlz (rel. int.): 530 [Mt (11), 485 (17), 412 (14), 411 (13), 332 (12), 
314 (13), 230 (11), 229 (26), 120 (32), 70 (100), 69 (11), 58 (66). 5: [af50 -48° (c 0.15; 
EtOH). UV A,max nm (log E): 237 (3.34), 214 (3.85). 1H NMR (500 MHz, CDC13): ada o 1.19 
(3H, d, J = 6.2 Hz, H-10), 1.24-1.90 (10H, m, H-3-7), 3.32 (lH, m, H-8), 3.59 (lH, dq, J = 6.4, 
6.2 Hz, H-9), 4.19 (IH, ddd, J = 7.6, 7.6, 10.1 Hz, H-2), 7.12 (lH, d, J = 10.1 Hz, NH), aib 
o 1.34 (3H, s, H-4), 1.77 (3H, s, H-3), 6.02 (lH, s, NH), Phe o 2.95 (lH, dd, J = 5.8, 13.5 Hz, 
H-3), 3.26 (lH, dd, J = 10.1, 13.5 Hz, H-3), 5.16 (IH, J = ddd, 5.8, 10.1, 10.1 Hz, H-2), 7.19-
7.29 (5H, m, H-5-9), 7.51 (lH, d, J = 10.1 Hz, NH), Pro o 1.24-1.90 (2H, m, H-3 and 4), 2.12-
2.35 (2H, m, H-3 and 4), 3.21 (lH, ddd, J = 7.6, 7.6, 10.1 Hz, H-5), 3.86 (IH, ddd, J = 4.1, 8.3, 
10.1 Hz, H-5), 4.66 (lH, dd, J = 2.3, 8.0 Hz, H-2). 13C NMR (125 MHz, CDC13): o 19.5, 23.6, 
24.7, 25.0, 25.2, 25.3, 26.5, 28.8, 29.1, 33.1, 35.8, 47.0, 53.4, 54.4, 57.8, 58.8, 70.9, 76.1, 
126.7, 128.6, 129.0, 137.0, 171.9, 172.8, 174.4, 175.6. ElMS m/z (rel. int.): 530 [Mt (11), 
486 (12), 485 (20), 430 (24), 412 (11), 411 (15), 332 (20), 314 (11), 229 (25), 120 (35), 70 
(100), 69 (12), 58 (64), 57 (11), 55 (15). 
4.3.3 Compound 4a 
A soln of 4 (3.2 mg, 0.0060 mmol) was dissolved in 2, 2-dimethoxypropane ( 1.0 ml) and a 
catalytic amount of p-toluenesulfonic acid was added and stirred for 30 min at room temp., 
and the solvent was then evaporated in vacuo. The residue was purified by silica gel column 
chromatography to give 4a (2.4 mg, 0.0042 mmol, 70%) as a colorless oil. 1H NMR (500 
MHz, CDC13): ada 0 1.13 (3H, d, J = 6.2 Hz, H-10), 1.23-1.85 (IOH, 1n, H-3-7), 1.33 (3H, s, 
CH3C), 1.44 (3H, s, CH3C), 4.01 (IH, m, H-8), 4.22 (IH, dq, J = 7.3, 6.2 Hz, H-9), 4.18 (IH, 
ddd, J = 7.6, 7.6, 10.1 Hz, H-2), 7.08 (IH, d, J = 10.1 Hz, NH), aib o 1.34 (3H, s, H-4), 1.77 
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(3H, s, H-3), 5.89 (lH, s, NH), Phe 8 2.95 (lH, dd, J = 5.7, 13.8 Hz, H-3), 3.26 (lH, dd, J = 
10.1, 13.8 Hz, H-3), 5.16 (lH, ddd, J = 5.7, 10.1, 10.1 Hz, H-2), 7.19-7.29 (5H, m, H-5-9), 
7.52 (lH, d, J =10.1 Hz, NH), Pro 8 1.23-1.85 (2H, m, H-3 and 4), 2.12-2.35 (2H, m, H-3 and 
4), 3.22 (lH, ddd, J = 7.6, 7.6, 10.1 Hz, H-5), 3.86 (1H, ddd, J = 4.2, 8.3, 9.6 Hz, H-5), 4.66 
(lH, dd, J = 2.2, 7.6 Hz, H-2). ElMS mlz (rel. int.): 570 [Mt (36), 556 (23), 555 (49), 513 
(20), 485 (26), 470 (26), 455 (23), 451 (21), 412 (35), 314 (21), 229 (26), 120 (34), 70 (100), 
58 (70). 
4.3.4 Compound Sa 
CompoundS (8.0 mg, 0.015 mmol) was treated with 2, 2-dimethoxypropane andp-
toluenesulfonic acid under the same conditions as 4 to give Sa (5.0 mg, 0.0088 mmol, 59%) 
as a colorless oil. 1H NMR (500 MHz, CDC13): ada 8 1.24 (3H, d, J = 6.0 Hz, H-10), 1.26-
1.86 (lOH, m, H-3-7), 1.38 (3H, s, CH3C), 1.39 (3H, s, CH3C), 3.49 (lH, 111, H-8), 3.69 (lH, 
dq, J = 8.0, 6.0 Hz, H-9), 4.18 (lH, ddd, J = 7.8, 7.8, 10.1 Hz, H-2), 7.08 (lH, d, J = 10.1 Hz, 
NH), aib 8 1.34 (3H, s, H-4), 1.77 (3H, s, H-3), 5.87 (lH, s, NH), Phe 8 2.95 (lH, dd, J = 5.7, 
13.5 Hz, H-3), 3.26 (lH, dd, J = 10.1, 13.5 Hz, H-3), 5.16 (lH, ddd, J = 5.7, 10.1, 10.1 Hz, H-
2), 7.19-7.30 (5H, 1n, H-5-9), 7.50 (lH, d, J = 10.1 Hz, NH), Pro 8 1.26-1.90 (2H, m, H-3 and 
4), 2.13-2.36 (2H, 111, H-3 and 4), 3.22 (lH, ddd, J = 7.4, 7.5, 10.0 Hz, H-5), 3.86 (lH, ddd, J 
= 4.6, 8.5, 10.1 Hz, H-5), 4.66 (lH, dd, J = 2.3, 7.8 Hz, H-2). ElMS m/z (rel. int.): 570 [Mt 
(16), 556 (9), 555 (29), 513 (11), 485 (14), 470 (14), 455 (13), 451 (13), 412 (19), 314 (14), 
229 (18), 120 (27), 70 (100), 58 (75). 
4.3.S Compound 6 
A mixture of 4 and S (39.6 mg, 0.075 mmol) in MeOH (2.0 ml) was added to a soln of 
Nal04 (19.3 mg) in H20 (2.0 ml) at 0°C. After being stirred at room temp. for 1 hour, the 
reaction mixture was diluted with 20 ml of H20. The products were extracted with EtOAc 
(18 ml x 3). The EtOAc soln was dried over Na2S04 and evaporated in vacuo. The residue 
was purified by HPLC (70% MeOH) to give 6 (33.9 mg, 0.070 mmol, 93%, Rt 21.5 min) as a 
colorless oil. [af5 0 -51 o (c 0.13; EtOH). UV Amax nm (log£): 236 (3.40), 211 (3.85). 1H NMR 
(500 MHz, CDC13): aoa 8 1.21-1.85 (8H, m, H-3-6), 2.43 (2H, dt, 1.4, 7.4 Hz, H-7), 4.18 (lH, 
ddd, J = 7.6, 7.8, 10.3 Hz, H-2), 7.07 (lH, d, J = 10.3 Hz, NH), 9.76 (lH, t, J = 1.4 Hz, H-8), 
aib 8 1.34 (3H, s, H-4), 1.77 (3H, s, H-3), 5.93 (lH, s, NH), Phe 8 2.95 (lH, dd, J = 5.8, 13.5 
Hz, H-3), 3.26 (lH, dd, J = 10.3, 13.5 Hz, H-3), 5.16 (lH, ddd, J = 5.8, 10.3, 10.3 Hz, H-2), 
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7.19-7.29 (5H, 111, H-5-9), 7.50 (lH, d, J = 10.3 Hz, NH), Pro 8 1.21-1.85 (2H, m, H-3 and 4), 
2.10-2.36 (2H, 111, H-3 and 4), 3.22 (lH, ddd, J = 7.6, 7.6, 10.1 Hz, H-5), 3.86 (lH, ddd, J = 
4.1, 8.7, 10.1 Hz, H-5), 4.66 (lH, dd, J = 2.4, 7.8 Hz, H-2). 13C NMR (125 MHz, CDCl,): 
() 21.8, 23.5, 24.7, 25.0, 25.3, 26.5, 28.72, 28.73, 35.8, 43.7, 47.0, 53.4, 54.3, 57.8, 58.8, 126.7, 
128.6, 129.0, 137.0, 171.8, 172.8, 174.3, 175.6, 202.5. ElMS m/z (rel. int.): 484 [Mt (17), 
428 (14), 427 (14), 399 (13), 384 (33), 365 (24), 356 (30), 286 (26), 229 (27), 128 (19), 120 
(38), 70 ( 100), 58 (71 ). 
4.3.6 Compound 7 
A soln of 6 ( 11.2 mg, 0.023 mmol) and N aBH4 ( 1.2 mg) in dry MeOH ( 1.0 ml) was stirred 
for 15 min at room temp. The reaction mixture was diluted with 10 ml of brine (pH 2.0 with 
HCl), after which the products were extracted with EtOAc (10 ml x 3). The EtOAc extract 
was dried over Na2S04 and evaporated in vacuo. The residue was purified by HPLC (70% 
MeOH) to give 7 (9.3 mg, 0.019 mmol, 83%, Rt 22.8 min) as a colorless oil. [a] 25 0 -54° (c 
0.16; EtOH). UV Amax nm (log E): 236 (3.45), 214 (3.78). 1H NMR (500 MHz, CDCl3): aoa 
8 1.25-1.86 (lOH, n1, H-3-7), 3.63 (2H, t, J = 6.5 Hz, H-8), 4.19 (lH, ddd, J = 7.6, 7.8, 10.1 
Hz, H-2), 7.10 (lH, d, J = 10.1 Hz, NH), aib 81.34 (3H, s, H-4), 1.77 (3H, s, H-3), 5.98 (lH, s, 
NH), Phe 8 2.95 (lH, dd, J = 5.8, 13.6 Hz, H-3), 3.26 (lH, dd, J = 10.1, 13.6 Hz, H-3), 5.16 
(lH, J = ddd, 5.8, 10.1, 10.1 Hz, H-2), 7.17-7.29 (5H, m, H-5-9), 7.52 (lH, d, J = 10.1 Hz, 
NH), Pro 8 1.25-1.86 (2H, 111, H-3 and 4), 2.12-2.36 (2H, 111, H-3 and 4), 3.22 (lH, ddd, J = 
7.6, 7.6, 10.3 Hz, H-5), 3.86 (lH, ddd, J = 4.1, 8.7, 10.3 Hz, H-5), 4.66 (lH, dd, J = 1.6, 7.6 
Hz, H-2). 13C NMR (125 MHz, CDC13): 8 23.6, 24.7, 25.0, 25.4, 25.5, 26.5, 28.9, 29.0, 32.5, 
35.8, 47.0, 53.4, 54.4, 57.8, 58.8, 62.9, 126.7, 128.6, 129.0, 137.0, 171.8, 172.8, 174.4, 175.6. 
ElMS m/z (rel. int.): 486 [Mt (12), 430 (16), 429 (18), 387 (19), 386 (69), 367 (30), 314 (14), 
288 (29), 229 (51), 227 (18), 217 (13), 201 (13), 131 (10), 130 (24), 120 (48), 70 (100), 58 
(96). 
4.3. 7 Compound 8 
To a soln of 6 (33.9 mg, 0.070 mmol) in CH2Cl2 (2.5 ml) was added 1, 3-propanedithiol 
(0.0098 ml, 15.0 mg, 0.14 mmol) and boron trifluoride-diethyl ether complex (0.026 ml, 29.8 
mg, 0.098 mmol) at 0°C. After being stirred at room temp. for 30 min, the reaction mixture 
was diluted with EtOAc (10 ml). The EtOAc extract was washed with saturated NaHC03 and 
brine, dried over N~S04 and evaporated in vacuo to give thioacetal6a (21.9 mg, 0.038 mmol, 
26 
54%) as a colorless oil. 1H NMR (500 MHz, CDC13): aoa o 1.25-1.92 (12H, m, H-3-7 and 
SCH2CH2), 2.77-2.89 (4H, m, SCH2), 4.02 (lH, dd, J = 6.9, 7.0 Hz, H-8), 4.17 (lH, ddd, J = 
7.6, 7.6, 10.0 Hz, H-2), 7.09 (lH, d, J = 10.0 Hz, NH), aib o 1.33 (3H, s, H-4), 1.76 (3H, s, H-
3), 6.00 (lH, s, NH), Phe o 2.94 (lH, dd, J = 5.7, 13.5 Hz, H-3), 3.25 (lH, dd, J = 10.3, 13.5 
Hz, H-3), 5.15 (lH, ddd, J = 5.7, 10.3, 10.3 Hz, H-2), 7.18-7.30 (5H, m, H-5-9), 7.52 (lH, d, J 
= 10.3 Hz, NH), Pro 81.25-1.92 (2H, m, H-3 and 4), 2.07-2.34 (2H, m, H-3 and 4), 3.21 (lH, 
ddd, J = 7.6, 7.6, 10.3 Hz, H-5), 3.84 (lH, ddd, J = 5.0, 8.6, 10.3 Hz, H-5), 4.65 (lH, dd, J = 
2.7, 8.4 Hz, H-2). ElMS mlz (rel. int.): 574 [Mr (27), 330 (53), 245 (15), 244 (76), 153 (49), 
142 (33), 125 (80), 120 (21), 119 (56), 108 (21), 107 (12), 106 (100), 91 (41), 78 (20), 73 (15), 
70 (70), 64 (30), 60 (15), 58 (37). 
A soln of 6a (21.9 mg, 0.038 mmol) in dioxane (2.0 ml) was refluxed for 20 min with 
Raney Ni (700 mg) freshly prepared from alloy. The soln was filtered, the metal washed 
thoroughly with methanol, and the filtrate and washings evaporated in vacuo. The residue was 
purified by prep. TLC [EtOAc-n-hexane, 4:6, Rf0.51] and then HPLC (70% MeOH) to give 8 
(10.5 mg, 0.022 mmol, 58%, R1 26.8 min) as a colorless oil. [aF50 -63° (c 0.24; EtOH). UV 
Amax nm (log£): 236(3.52), 212 (3.92). 1H NMR (500 MHz, CDC13): aoa o 0.88 (3H, t, J = 7.1 
Hz, H-8), 1.20-1.90 (lOH, 1n, H-3-7), 4.18 (lH, ddd, J = 7.3, 7.6, 10.2 Hz, H-2), 7.07 (lH, d, J 
= 10.2 Hz, NH), aib o 1.34 (3H, s, H-4), 1.77 (3H, s, H-3), 5.91 (lH, s, NH), Phe o 2.95 (lH, 
dd, J = 5.7, 13.5 Hz, H-3), 3.27 (lH, dd, J = 10.1, 13.5 Hz, H-3), 5.16 (lH, ddd, J = 5.7, 10.1, 
10.1 Hz, H-2), 7.19-7.29 (5H, m, H-5-9), 7.53 (lH, d, J = 10.1 Hz, NH), Pro 81.20-1.90 (2H, 
m, H-3 and 4), 2.14-2.36 (2H, 1n, H-3 and 4), 3.23 (lH, ddd, 1= 7.3, 7.3, 10.1 Hz, H-5), 3.86 
(lH, ddd, J = 5.5, 8.6, 10.1 Hz, H-5), 4.66 (lH, dd, J = 2.1, 8.0 Hz, H-2). 13C NMR (125 MHz, 
CDC13): 14.0, 22.5, 23.6, 24.7, 25.0, 25.5, 26.5, 28.9 x 2, 31.6, 35.8, 47.0, 53.4, 54.5, 57.8, 
58.8, 126.7, 128.6, 129.0, 137.1, 171.8, 172.8, 174.5, 175.7. ElMS mlz (rel. int.): 470 [Mr 
(34), 370 (60), 351 (31), 229 (34), 120 (37), 70 (100), 58 (69). 
4.3.8 Compound 9 
Compound 2 (5.9 mg, 0.012 mmol) in CH2Cl2 (0.5 ml) was treated with 1, 3-propanedithiol 
(0.017 ml, 2.6 mg, 0.024 mmol) and boron trifluoride-diethyl ether complex (0.046 ml, 5.2 
mg, 0.017 mmol) under the same conditions used in the preparation of 6a to give thioketal 2a 
(5.1 mg, 0.0085 mmol, 71 %) as a colorless oil. 1H NMR (500 MHz, CDC13): ada o 0.97 (3H, t, 
J = 7.4 Hz, H-10), 1.24-1.97 (14H, m, H-3-7, 9 and SCH2CH2), 2.75-2.84 (4H, m, SCH2), 
4.17 (lH, ddd, J = 7.6, 7.6, 10.1 Hz, H-2), 7.08 (lH, d, J = 10.1 Hz, NH), aib o 1.34 (3H, s, 
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H-4), 1.77 (3H, s, H-3), 5.92 (IH, s, NH), Phe () 2.95 (lH, dd, J = 5.7, 13.6 Hz, H-3), 3.26 
(lH, dd, J = 10.1, 13.6 Hz, H-3), 5.16 (lH, ddd, J = 5.7, 10.1, 10.3 Hz, H-2), 7.18-7.29 (5H, 
m, H-5-9), 7.52 (lH, d, J = 10.3 Hz, NH), Pro() 1.24-1.97 (2H, m, H-3 and 4), 2.13-2.36 (2H, 
m, H-3 and 4), 3.22 (lH, ddd, J = 7.3, 7.3, 10.1 Hz, H-5), 3.86 (lH, ddd, J = 4.4, 8.3, 10.1 Hz, 
H-5), 4.65 (lH, dd, J = 2.5, 8.0 Hz, H-2). ElMS mlz (rel. int.): 602 [Mt (52), 502 (19), 496 
(24), 229 (24), 147 (45), 120 (40), 73 (19), 70 (100), 69 (22), 60 (22), 58 (68), 57 (24), 55 
(25). 
Compound 2a (5.1 mg, 0.0085 mmol) was treated with Raney Ni (100 mg) under the same 
conditions used in the preparation of 8. The product was purified by silica gel column 
chromatography followed by HPLC (90% MeOH) to give 9 (1.5 mg, 0.0030 mmol, 35%, R1 
26.8 min) as a colorless oil. 1H NMR (500 MHz, CDC13): ada() 0.88 (3H, t, J = 6.9 Hz, H-10), 
1.24-1.86 (14H, m, H-3-9), 4.18 (lH, ddd, J = 7.6, 7.6, 10.1 Hz, H-2), 7.07 (lH, d, J = 10.1 
Hz, NH), aib () 1.34 (3H, s, H-4), 1.77 (3H, s, H-3), 5.89 (lH, s, NH), Phe () 2.95 (IH, dd, J = 
5.7, 13.5 Hz, H-3), 3.26 (lH, dd, J = 10.1, 13.5 Hz, H-3), 5.16 (lH, ddd, J = 5.7, 10.1, 10.1 
Hz, H-2), 7.19-7.29 (5H, m, H-5-9), 7.53 (lH, d, J = 10.1 Hz, NH), Pro() 1.24-1.86 (2H, m, 
H-3 and 4), 2.14-2.36 (2H, m, H-3 and 4), 3.22 (lH, ddd, J = 7.3, 7.3, 10.1 Hz, H-5), 3.86 
(lH, ddd, J = 4.4, 8.3, 10.1 Hz, H-5), 4.66 (lH, dd, J = 2.1, 7.6, H-2). ElMS mlz (rel. int.): 
498 [Mt (34), 399 (22), 398 (63), 386 (18), 379 (30), 229 (34), 142 (15), 120 (36), 70 (100), 
58 (66). 
4.3.9 Compound 10 
N-Boc-L-2-aminobutyryl-2-aminoisobutyric acid methyl ester 
L-Aba (103.0 mg, 1 mmol) in dioxane (1.0 ml) and H20 ( 1.0 ml) was coupled with N-Boc 
azide (290 mg, 1.6 mmol) under alkali conditions to give N-Boc-L-aba (183.4 mg, 0.90 mmol, 
90%). 1H NMR (500 MHz, CDC13): aba () 0.99 (3H, t, J = 7.4 Hz, H-4), 1.45 (9H, s, (CHJ,C), 
1.73 (lH, m, H-3), 1.92 (lH, m, H-3), 4.11 (1H, m, H-2), 4.27 (lH, m, NH), 4.99 (lH, m, NH). 
FABMS m/z: 204 [M+Ht. 
Aib methyl ester hydrochloride (10.5 mg, 0.070 mmol) that was prepared by the method 
reported by Pastuszak et al. (1982) in EtOAc (0.5 ml) was neutralized with triethylamine 
(0.0098 ml, 7.17 mg, 0.070 mmol) and coupled with the N-Boc-L-aba (15.2 mg, 0.075 mmol) 
by use ofEEDQ (18.9 mg, 0.075 mmol) in EtOAc (0.1 ml) to give the title compound (16.5 
mg, 0.055 mmol, 79%). 1H NMR (500 MHz, CDC13): aba () 0.94 (3H, t, J = 7.4 Hz, H-4), 1.45 
(9H, s, (CH3 ) 3 C), 1.62 (lH, m, H-3), 1.84 (lH, m, H-3), 3.96 (lH, m, H-2), 4.99 (lH, m, 
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NH), aib 8 1.54 (3H, s, H-3 or 4), 1.55 (3H, s, H-3 or 4), 3.73 (3H, s, CH,O), 6.67 (lH, s, NH). 
FABMS mlz (rel. int.): 325 [M+Nat, 303 [M+Ht. 
4.3.10 N-Boc-L-2-aminobutyryl-2-aminoisobutyryl-L-phenylalanyl-D-proline methyl 
ester 
N-Boc-L-aba-aib methyl ester ( 16.5 mg, 0.055 mmol) in MeOH (0.11 ml) was saponified 
with 1M NaOH (0.083 ml) to give the acid (14.2 mg, 0.049 mmol, 89%). 1H NMR (500 MHz, 
CDC13): aba 8 0.93 (3H, t, J = 7.6 Hz, H-4), 1.43 (9H, s, (CH_,)_,C), 1.61 (lH, m, H-3), 1.82 
(lH, m, H-3), 4.01 (lH, m, H-2), 5.05 (lH, m, NH), aib 8 1.52 (3H, s, H-3 or 4), 1.53 (3H, s, 
H-3 or 4), 6.65 (lH, s, NH). CIMS mlz (rel. int.): 289 [M+Ht (18), 233 (100). 
L-Phe-D-Pro methyl ester trifluoroacetate (82.5 mg, 0.23 mmol), which was prepared by the 
method repmted by Pastuszak et al. (1982), in CHC13 (2.0 ml) was neutralized with 
triethylamine (0.032 ml, 23.4 mg, 0.23 mmol) and coupled with theN-protected 
dipeptide acid (95 mg, 0.33 mmol) in DMF (0.8 ml) by use ofHOBt (40.2 mg, 0.26 mmol) in 
DMF (0.5 ml) and DCC (56.5 mg, 0.26 mmol) in CHC13 (0.5 ml) to give the title compound 
(99.7 mg, 0.18 mmol, 78%). 1H NMR (500 MHz, CDC13): aba 8 0.95 (3H, t, J = 7.3 Hz, H-4), 
1.58-1.89 (2H, m, H-3), 1.45 (9H, s, ( CH3) 3 C), 3.97 (lH, m, H-2), 5.11 (lH, d, J = 5.8 Hz, 
NH), aib 8 1.53 (3H, s, H-3 or 4), 1.55 (3H, s, H-3 or 4), 6.72 (lH, s, NH), Phe 8 2.95 (lH, dd, 
J = 9.2, 13.1 Hz, H-3), 3.05 (lH, dd, J = 6.0, 13.1 Hz, H-3), 4.91 (lH, ddd, J = 6.0, 9.2, 9.2 
Hz, H-2), 6.96 (lH, d, J = 9.2 Hz, NH), 7.16-7.27 (5H, 111, H-5-9), Pro 8 1.58-1.89 (4H, 111, H-
3 and 4), 2.71 (lH, ddd, J = 2.7, 6.9, 7.1 Hz, H-5), 3.54 (1H, m, H-5), 3.69 (3H, s, CH30), 
4.30 (lH, dd, J = 3.7, 8.3 Hz, H-2). ElMS 111/z (rel. int.): 546 [Mt (16), 271 (27), 259 (11), 
243 (14), 215 (30), 187 (19), 130 (58), 120 (43), 70 (25), 58 (100), 57 (20). 
4.3.11 Cyclo (L-2-aminobutyryl-2-aminoisobutyryl-L-phenylalanyl-D-prolyl) (10) 
TheN-protected tetrapeptide methyl ester (18.2 mg, 0.033 mmol) in MeOH (0.66 ml) was 
saponified with 1M NaOH (0.50 ml) to give the acid (14.9 mg, 0.028 mmol, 85%). 1H NMR 
(500 MHz, CDC13): aba 8 0.93 (3H, t, J = 7.4 Hz, H-4), 1.55-1.88 (2H, 1n, H-3), 1.44 (9H, s, 
(CH3) 3 C), 4.00 (lH, m, H-2), 5.43 (lH, d, J = 6.9 Hz, NH), aib 8 1.51 (6H, s, H-3 and 4), 7.02 
(lH, s, NH), Phe 8 2.95 (lH, m, H-3), 3.05 (lH, 111, H-3), 4.92 (lH, ddd, J = 6.9, 8.6, 8.6 Hz, 
H-2), 7.17-7.28 (5H, m, H-5-9), 7.41 (lH, d, J = 6.9 Hz, NH), Pro 8 1.55-1.88 (4H, 111, H-3 
and 4), 2.68 (lH, 111, H-5), 3.65 (1H, m, H-5), 4.31 (lH, dd, J = 3.7, 8.0 Hz, H-2). ElMS m!z 
(rel. int.): 532 [Mt (5), 488 (7), 332 (7), 271 (14), 243 (15), 217 (12), 215 (18), 201 (13), 187 
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(14), 186 (6), 130 (6), 120 (37), 116 (32), 102 (9), 91 (5), 70 (26), 59 (6), 58 (100), 57 (20). 
TheN-protected tetrapeptide acid (20.5 mg, 0.038 mmol) in CH2Cl2 (0.5 ml) was coupled 
with HOSu (8.9 mg, 0.076 mmol) in DMF (200 !11) by use of DCC (9.1 mg, 0.042 mmol) in 
CH2Cl2 (200 !Jl). The succinimide ester was N-deprotected using TFA (0.38 ml). The TFA salt 
was dissolved in DMF (2.0 ml) and then cyclized by being slowly added to a large volume of 
pyridine (60 ml). The pyridine was evaporated in vacuo. The residue was purified by silica gel 
column chromatography followed by HPLC (85% MeOH) to give the cyclic peptide 10 (4.1 
mg, 0.01 mmol, 26%, Rt 16.2 min) as a colorless powder. [a,f50 -71 ° (c 0.19; EtOH). UV "-max 
nm (log E): 236 (3.09), 209 (3.67). 1H NMR (500 MHz, CDC13): aba 8 0.91 (3H, t, J = 7.3 Hz, 
H-4), 1.59-1.91 (2H, 1n, H-3), 4.11 (lH, ddd, J = 7.6, 7.6, 10.3 Hz, H-2), 7.09 (lH, d, J = 10.3 
Hz, NH), aib 8 1.34 (3H, s, H-4), 1.77 (3H, s, H-3), 5.92 (lH, s, NH), Phe 8 2.95 (lH, dd, J = 
5.7, 13.5 Hz, H-3), 3.26 (lH, dd, J = 10.1, 13.5 Hz, H-3), 5.16 (lH, ddd, J = 5.7, 10.1, 10.1 
Hz, H-2), 7.19-7.29 (5H, 111, H-5-9), 7.52 (lH, d, J = 10.1 Hz, NH), Pro 8 1.59-1.91 (2H, 111, 
H-3 and 4), 2.13-2.36 (2H, 1n, H-3 and 4), 3.22 (lH, ddd, J = 7.4, 7.6, 10.3 Hz, H-5), 3.86 (lH, 
ddd, J = 4.8, 8.7, 10.3 Hz, H-5), 4.66 (dd, J = 2.5, 7.8 Hz, H-2). 13C NMR (125 MHz, CDC13): 
10.1, 22.3, 23.6, 24.7, 25.0, 26.5, 35.8, 47.0, 53.4, 55.9, 57.8, 58.8, 126.7, 128.6, 129.0, 137.0, 
171.9, 172.8, 174.4, 175.7. ElMS m/z (rel. int.): 414 [Mt (29), 371 (12), 314 (43), 302 (14), 
295 (19), 229 (27), 120 (44), 70 (100), 58 (91). 
4.3.12 Compound 11 
N-Boc-L-norleucyl-2-aminoisobutyric acid methyl ester 
L-Nle (131.2 mg, 1 mmol) in dioxane (2.0 ml) and H20 (1.0 ml) was coupled with N-Boc 
azide to give N-Boc-L-nle (197 mg, 0.85 mmol, 85%). 1H NMR (500 MHz, CDC13) nle 8 0.91 
(3H, t, J = 7.1 Hz, H-6), 1.30-1.90 (6H, 1n, H-3-5), 1.45 (9H, s, (CH3)3 C), 4.12 (lH, 111, H-2), 
4.29 (lH, dd, J = 7.6, 13.1 Hz, NH), 4.96 (lH, d, J = 7.6 Hz, NH). FABMS m/z: 254 [M+Nat, 
232 [M+Ht. 
Aib methyl ester hydrochloride (13.7 mg, 0.091 mmol) was neutralized with triethylamine 
and coupled with N-Boc-L-nle (23.2 mg, 0.10 mmol) by use of EEDQ to give the title 
compound (21.1 mg, 0.064 mmol, 70%). 1H NMR (500 MHz, CDC13): nle 8 0.89 (3H, t, J = 
7.1, H-6), 1.30-1.80 (6H, m, H-3-5), 1.45 (9H, s, (CH3)3C), 4.00 (lH, 111, H-2), 4.95 (1H, m, 
NH), aib 8 1.53 (3H, s, H-3 or 4), 1.55 (3H, s, H-3 or 4), 3.73 (3H, s, OCH_,), 6.59 (lH, s, NH). 
CIMS m/z (rel. int.): 331 [M+Ht (58), 275 (100). 
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4.3.13 N-Boc-L-norleucyl-2-aminoisobutyryl-L-phenylalanyl-D-proline methyl ester 
TheN-protected dipeptide methyl ester (48.5 mg, 0.15 mmol) was saponified with 1M 
NaOH to give the acid (41.9 mg, 0.13 mmol, 87%). 1H NMR (500 MHz, CDC13): nle 8 0.90 
(3H, t, J = 6.7 Hz, H-6), 1.44 (9H, s, (CH_),C), 1.30-1.85 (6H, m, H-3-5), 4.14 (lH, m, H-2), 
5.18 (lH, m, NH). aib 8 1.57 (3H, s, H-3 or 4), 1.59 (3H, s, H-3 or 4), 6.99 (lH, s, NH). CIMS 
mlz (rel. int.): 317 [M+Ht (52), 261 (100). 
L-Phe-D-Pro methyl ester trifluoroacetate (189.8 mg, 0.53 mmol) was neutralized with 
triethylamine and coupled with the N-Boc-L-nle (253 mg, 0.80 mmol) by use of HOBt and 
DCC to give the title compound (195.2 mg, 0.34 mmol, 64% ). 1H NMR (500 MHz, CDC13): 
nle 8 0.90 (3H, t, J = 6.9 Hz, H-6), 1.30-2.00 (6H, m, H-3-5), 1.45 (9H, s, (CH3 ) 3 C), 4.01 (lH, 
m, H-2), 4.78 (lH, 1n, NH), aib 8 1.50 (3H, s, H-3 or 4), 1.55 (3H, s, H-3 or 4), 5.54 (lH, br. s, 
NH), Phe 8 2.95 (lH, dd, J = 9.4, 12.9 Hz, H-3), 3.03 (lH, dd, J = 4.9, 12.9 Hz, H-3), 4.91 
(lH, ddd, J = 4.9, 8.9, 9.4 Hz, H-2), 7.15-7.31 (6H, m, H-5-9), 7.46 (lH, br. s, NH), 4.95 (lH, 
1n, NH), Pro 8 1.30-2.00 (4H, 1n, H-3 and 4), 2.72 (IH, ddd, 1 = 2.8, 6.9, 7.1 Hz, H-5), 3.54 
(IH, 111, H-5), 3.71 (3H, s, CH30), 4.30 (lH, dd, J = 3.7, 8.3 Hz, H-2). ElMS mlz (rel. int.): 
574 [Mt (15), 346 (13), 299 (30), 271 (12), 261 (14), 259 (14), 243 (31), 215 (16), 185 (11), 
131 (12), 130 (78), 128 (12), 120 (50), 86 (24), 70 (35), 58 (100), 57 (26), 56 (12). 
4.3.14 Cyclo (L-norleucyl-2-aminoisobutyryl- L-phenylalanyl-D-prolyl) (11) 
TheN-protected tetrapeptide methyl ester (46.0 mg, 0.084 mmol) was saponified with 1 M 
NaOH to give the acid (40.7 mg, 0.073 mmol, 87%). 1H NMR (500 MHz, CDC13): nle 8 0.88 
(3H, d, J = 6.9 Hz, H-6), 1.24-2.00 (6H, 111, H-3-5), 1.43 (9H, s, (CH_,}3C), 4.09 (lH, m, H-2), 
5.54 (lH, 111, NH), aib 8 1.43 (3H, s, H-3 or 4), 1.50 (3H, s, H-3 or 4), 7.47 (lH, 1n, NH), Phe 
8 2.90 (lH, dd, J = 6.0, 12.8 Hz, H-3), 2.98 (lH, dd, J = 9.4, 12.8 Hz, H-3), 4.78 (lH, m, H-2), 
7.18-7.26 (5H, m, H-5-9), 5.54 (lH, m, NH), Pro 8 1.24-2.00 (4H, m, H-3 and 4), 2.67 (lH, m, 
H-5), 3.53 (lH, 111, H-5), 4.19 (lH, 111, H-2). ElMS m/z (rel. int.): 560 [Mt (8), 299 (17), 271 
(16), 243 (21), 217 (14), 215 (14), 202 (20), 130 (23), 126 (13), 120 (52), 116 (37), 91 (11), 
86 (33), 70 (41), 58 (100), 56 (11). 
TheN-protected tetrapeptide acid (7.0 mg, 0.013 mmol) was converted to the 
corresponding N-hydroxysuccinimide ester. The succinimide ester was N-deprotected by use 
of TFA and then cyclized in pyridine. The crude product was purified by silica gel column 
chromatography followed by HPLC (85% MeOH) to give the cyclic peptide 11 ( 1.3 mg, 
0.0030 mmol, 23%, Rt 20.3 min) as a colorless powder. [a] 250 -44° (c 0.10; EtOH). UV Amax 
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nm (log c): 237 (3.36), 213 (3.76). 1H NMR (500 MHz, CDC13): nle o 0.90 (3H, t, J = 7.1 Hz, 
H-6), 1.14-1.85 (6H, m, H-3-5), 4.18 (lH, ddd, J = 7.6, 7.8, 10.3 Hz, H-2), 7.10 (lH, d, J = 
10.3 Hz, NH), aib o 1.34 (3H, s, H-4), 1.77 (3H, s, H-3), 5.97 (lH, s, NH), Phe o 2.95 (lH, dd, 
J = 5.7, 13.6 Hz, H-3), 3.26 (lH, dd, J = 10.1, 13.6 Hz, H-3), 5.16 (lH, ddd, J = 5.7, 10.1, 
10.3 Hz, H-2), 7.19-7.29 (5H, m, H-5-9), 7.54 (lH, d, J = 10.3 Hz, NH), Pro o 1.14-1.81 (2H, 
1n, H-3 and 4), 2.12-2.35 (2H, m, H-3 and 4), 3.22 (lH, ddd, J = 7.3, 7.4, 10.3 Hz, H-5), 3.86 
(lH, ddd, J = 4.4, 8.3, 9.9 Hz, H-5), 4.66 (dd, J = 2.1, 7.8 Hz, H-2). 13C NMR (125 MHz, 
CDC13): 13.9, 22.4, 23.6, 24.7, 25.0, 26.5, 27.7, 28.6, 35.8, 47.0, 53.4, 54.4, 57.8, 58.8, 126.7, 
128.6, 129.0, 137.0, 171.8, 172.8, 174.5, 175.7. ElMS m/z (rel. int.): 442 [Mt (34), 399 (10), 
343 (12), 342 (51), 330 (15), 323 (25), 314 (12), 229 (35), 217 (10), 183 (12), 120 (44), 86 
(19), 70 ( 100), 58 (80). 
4.3.15 Biological assays 
The retardant activity of compounds 1 and 4-11 was determined with the same procedures 
as described Chapter 3.3 .1. 
4.4 References 
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Chapter 5 
Mechanisms of retardation 
5.1 Introduction 
In the previous chapter, I showed that there are two types of retardant in chlamydocin 
analogues. One, for example in compound 1, requires the oxygen atom at C-8 of aod moiety 
to show the retardant activity. The other, for example in compound 8, requires no oxygen 
atom at the C-8 position but requires a specific length of alkyl group to show the activity. The 
shoots of rice seedlings treated with 8 were markedly curved, suggesting that the dwarfism 
induced by 8 was apparently different from that induced by 1. To understand the mechanism 
of their action, I focused on the contents of endogenous GAs and endogenous ABA. GAs are 
known to stimulate shoot elongation in higher plants. GA 1 is the active GAin the rice plant, 
and promotes shoot elongation (Graebe, 1987). ABA is involved in many physiological 
responses in plant development and sometimes shows inhibitory activity, although the role of 
this hormone is not clearly defined (Zeevaart and Creelman, 1988). 
Chlamydocin and HC-toxin (Fig. 5-1) have been repmted to inhibit HDAC activity (Brosch 
et al., 1995). HDACs are enzymes that regulate the gene expression (Wolffe, 1996), and their 
inhibition causes cell differentiation and cell cycle arrest (Yoshida et al., 1995). It had been 
proposed that epoxyketone unit of aeo is essential for the HDAC inhibitory activity (Fummai, 
et al. 2001). However apicidins and their analogues have been repmted to have the inhibitory 
activity without the epoxide of aeo (Singh et al., 2002). Therefore, I also tested the HDAC 
inhibitory activity of compounds 1 and 8. 
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Fig. 5-1 Stmctures of compounds 1 and 8, chlamydocin, HC-toxin and apicidin 
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I describe here the levels of endogenous ABA and GA1 in the rice seedlings whose 
dwarfism was induced by 1 or 8. In addition, HDAC inhibitory activity of compounds 4-8 is 
described in comparison with trichostatin A (Fig. 5-2), which is a potent inhibitor of HDACs. 
0 0 
~NHOH 
H3c-NJ0 CH3 CH3 
I 
CH3 
Fig. 5-2 Structure of trichostatin A 
5.2 Results and discussion 
To determine the mechanisms of the dwarfism induced by these two types of retardant, the 
changes of the endogenous GA1 and ABA levels caused by compounds 1 and 8 were 
investigated. Ten nmol/plant of 1 or 30 nmol/plant of 8 was applied to the seedlings as in the 
bioassay to equalize the retardation effect. The aerial parts of the treated rice seedlings were 
homogenized in 80% acetone and filtrated. The filtrates were concentrated in vacuo and the d6 
ABA was added to the aqueous concentrate. This solution was subjected to a solvent 
fractionation to give the acidic ethyl acetate (AE) fraction, which was purified by HPLC after 
passing through a Sep-Pak C18 Cmtridge. The ABA equivalent fractions from HPLC were 
combined and analyzed by LC-MS. On the other hand, the GA1 equivalent fractions from 
HPLC were combined and analyzed by ELISA after methylation with CH2N2. GC-SIM 
analysis after methylation and trimethylsilylation of the HPLC fractions confi1med the 
occurrence of GA1 in these fractions. The hormonal levels determined in the treated plants are 
shown in Table 5-2. In the rice plants treated with 1, the ABA level was four times higher than 
that of the control, and the GA1 level was 20% of that of the control. In the rice plant treated 
with 8, the ABA level was almost the same as that of the control, and the GA1 level was 5% of 
that of the control. These results indicated that the increase in the ABA level and the decrease 
Table 5-2 The endogenous levels of ABA and GA1 in the aerial parts of the rice seedlings 
treated with compound 1 (10 nmol/plant) or 8 (30 nmol/plant) 
ABA (ng/g) GA1 (pg/g) 
Control 2.2 315.9 
1 9.1 60.3 
8 2.3 15.9 
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in the GA1 level caused growth retardation in the case of 1, and the dramatic reduction of the 
GA1 level caused it in the case of 8. The exogenously applied ABA reduced the height of the 
rice seedlings, and thus it is reasonable that the accumulation of endogenous ABA causes such 
effects (data not shown). Compounds 1 and 8 both reduced endogenous GA1 levels in the 
treated rice seedlings. There is an impmtant and interesting question, which step in GA 
biosynthesis they inhibit, still remains to be solved. 
I also investigated the HDAC inhibitory activity of compounds 1 and 8 (Table 5-3). 
Compound 1 was as active as trichostatin A, which is a potent inhibitor of HDACs. On the 
other hand, compound 8 did not have the inhibitory activity at 10000 nM. In the case of 1, an 
increase in ABA level and a decrease in GA1 level retarded plant growth. It is likely that 
HDAC inhibition stimulate the ABA synthesis as an adaptation to stress and an increase in 
ABA level may produce plant growth retardation. I tested the plant growth retardant activity 
of trichostatin A, and found that it did not have the retardant activity at the dose of 30 
nmol/plant. This revealed that HDAC inhibitory activity was not related to retardant activity 
of both compounds 1 and 8, confirming that the alteration of endogenous hormonal levels was 
not related to HDAC inhibition. 
Table 5-3 HDAC (nuclear extract from HeLa cell) inhibitory activity of compounds 1 and 4-8 
Compound R 10000 nM 1000 nM 100nM 10nM 
Trichostatin A 100 100 100 39 
1 COCH(R -OH)CH3 100 100 100 53 
4 CH(R -OH)CH(R -OH)CH3 40 17 
5 CH(S-OH)CH(R -OH)CH3 100 100 75 0 
6 CHO 70 32 0 0 
7 CH20H 0 0 0 0 
8 CH3 0 0 0 0 
Values are inhibition activity presented as percentage of the control. 
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Compounds 4-6 also inhibited the HDAC activity (Table 5-3). Compounds 4 and 5 were 
less active than 1. This indicated that the 8-oxo in aho is important for the inhibition like the 
retardation. Compound 6 was 100 fold less active than 1. This indicated that the 9-hydroxyl 
and/or alkyl group chain length of 1 was impmtant in the inhibition not like in the retardation. 
Singh et al. reported that the 9-hydroxyl in aho slightly enhanced the inhibitory activity 
(2000). This indicated that the alkyl group chain length of 1 was more impmtant than 9-
hydroxyl for the inhibitory activity. Surprisingly, compound 5 was 100 hold more active than 
4, indicating that the stereochemistry of 8-hydroxyl is impmtant. Singh et al. also reported the 
probability that the slight difference of the backbone conformation affect the inhibitory 
activity. Fmther studies on the alkyl group chain length and the backbone conformation may 
lead to the development of specific HDAC inhibitors. 
5.3 Experimental 
5.3.1 Extraction and purification of plant hormones 
Compound 1 (10 nmol/plant) or 8 (30 nmol/plant) in aq. MeOH was applied to the rice 
seedlings as in the bioassay described chapter 3.3.1. As a control only aq. MeOH was applied. 
After incubation for 72 h under continuous light, the aerial parts of the rice seedlings were 
collected. The weights of the plant materials collected were 8.2 (treated with 1), 8.4 (treated 
with 8) and 10.2 g (the control). Each plant material was homogenized in 60 ml of 80% aq. 
acetone. The homogenate was filtered and the debris was fmther extracted twice with 80% aq. 
acetone. The extracts were combined and concentrated in vacuo. The aq. residue equivalent to 
7.2 g of plant materials was diluted up to 100 ml by adding H20 and d6-ABA was added to it. 
The amounts of d6-ABA added were 144 (treated with 1), 100 (treated with 8) and 93 ng (the 
control). The aq. residue was adjusted to pH 2.5 with 6 M HCl, and extracted with EtOAc (80 
ml x 3). The EtOAc solution was extracted with saturated NaHC03 (50 ml x 3). The NaHC03 
solution was adjusted to pH 2.5 with 6 M HCl, and extracted with EtOAc (180 ml x 3). The 
EtOAc solution was dried over Na2S04 and evaporated in vacuo. The residue was dissolved in 
a small amount of 80% aq. MeOH, and loaded onto a Sep-Pak C18 Cattridge (Millipore). The 
eluate eluted from the cartridge with 7.5 ml of 80% aq. MeOH was evaporated. The residue 
was subjected to HPLC with a column of Capcell Pak C18 (Shiseido, 6.0 x 150 mm) and 
eluted with 0.5% AcOH in 10% aq. CH3CN (solvent A) and 0.5% AcOH in 80% aq. CH3CN 
(solvent B) at 30°C as follows: 0-10 min, elution with solvent A; 10-50 min, linem· gradient of 
0 to 100% solvent B. The flow rate of the solvent was 1.0 ml/min. Eluate was collected every 
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1 min as one fraction. The retention times of ABA and GA1 were 31 and 19 min, respectively. 
The authentic GA1 was a gift of Prof. Takeshi Sassa (Yamagata University, Yamagata, Japan) 
and (+)-ABA was purchased from Sigma. The d6-ABA was prepared according to the 
procedure of Mil borrow et al. (1971 ), and its purity and labeling pattern were checked with 1 H 
NMR and ElMS. 
5.3.2 LC-MS analysis for ABA 
Negative electrospray mass spectra were obtained using a Quattro micro mass spectrometer 
(Micromass, electrospray voltage: 3.5 kV; desolvation temp.: 400oC; sheath gas: N2) coupled 
with a JASCO PU-980 Gulliver LC system equipped with a PR-18 GP column (Kanto 
Chemical, 250 x 2.0 mm, 51-1m). For LC, a gradient system was used that started from 0.25% 
AcOH in 10% aq. CH3CN (solvent C) to 0.25% AcOH in 80% aq. CH3CN (solvent D) at 40°C 
as follows: 0-10 min, elution with solvent C; 10-50 min, linear gradient of 0 to 100% solvent 
D. The flow rate was 0.2 ml/min (injection volume: 10 1-11). The MRM was obtained during 
LC analysis under the following conditions: cone voltage, 30 V; collision energy, 13 e V; 
collision pressure, 1. 7 mT; collision gas, Ar. The MRM transitions from mlz 269 to 159 of the 
internal d6-ABA and from m/z 263 to 153 of the natural ABA were monitored, and these 
product ions of 159 and 153 were used for quantitation. 
5.3.3 GC-MS analysis for methyl trimethylsilyl GA1 
A portion of GA1 equivalent fraction from ODS-HPLC was subjected to GC/SIM analysis 
after methylation with CH2N2 and trimethylsilylation with N-methyl-N-trimethylsilyl 
trifluoroacetamide. A Trace MS (Thermo) equipped with a Trace GC 2000 (Thermo) and a 
capillary column SPB™-1 (Supelco, 30m x 0.25 mm) was used. The ionization voltage was 
70 e V. The GC conditions were as follows: injection temperature, 250°C; initial temperature, 
60°C (1.5 min); liner gradient up to 200°C at 60oC/min, to 280oC at 5°C/min, and maintained 
at 280°C (10 min). In the GC/SIM analysis, characteristic ions, m!z 506 (M+) and 448 were 
monitored. 
5.3.4 ELISA 
ELISA was performed according to the procedure of Yamaguchi et al. ( 1990). 
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5.3.5 HDAC inhibitory assays 
HDAC inhibition activity assays were conducted by the use of HDAC Colorimetric 
Activity Assay/Drug Discovery Kit-AK-501 instruction (Funakoshi), and according to the 
instruction. 
5.4 References 
Brosch, G., Ransom, R., Lechner, T., Walton, J.D., Loidl, P., 1995. Inhibition of maize histone 
deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum. Plant Cell 7, 
1941-1950. 
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., Horiuchi, S., 2001. Potent 
histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics 
including trapoxin. Proc. Natl. Acad. Sci. USA 98, 87-92. 
Graebe, J.E., 1987. Gibberellin biosynthesis and control. Ann. Rev. Plant Physiol. 38, 419-
465. 
Marks, P.A., Richon, V.M., Rifkind, R.A., 2000. Histone deacetylase inhibitors: Inducers of 
differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92, 1210-1216. 
Milborrow, B.V., 1971. Abscisic acid. In: Goodwin T.W. (Ed), Aspects ofTerpenoid 
Chemistry and Biochemistry. Academic Press, London, pp. 137-151. 
Singh, S.B., Zink, D.L., Liesch, J.M., Mosley, R.T., Dombrowski, A.W., Bills, G.F., Darkin-
Rattray, S.J., Schmatz, D.M., Goetz, M.A., 2002. Structure and chemistry of apicidins, a 
class of novel cyclic tetrapeptides without a terminal a-keto epoxide as inhibitors of 
histone deacetylase with potent antiprotozoal activities. J. Org. Chern. 67, 815-825. 
Wolffe, A.P., 1996. Histone deacetylase: A regulator of transcription. Science 272, 371-372. 
Yamaguchi, I., Nakazawa, R., Nakagawa, R., Suzuki, Y., Kurogochi, S., Murofushi, N., 
Takahashi, N., Weiler, E.W., 1990. Identification and semi-quantification of gibberellins 
from the pollen and anther of Zea mays by immunoassay and GC/MS. Plant Cell Physiol. 
31, 1063-1069. 
Yoshida, M., Horiuchi, S., Beppu, T., 1995. Trichostatin A and trapoxin: novel chemical 
probes for the role of histone acetylation in chromatin structure and function. BioEssays 
17' 423-430. 
Zeevaart, J.A.D. and Creelman, R.A., 1988. Metabolism and physiology of abscisic acid. Ann. 
Rev. Plant Physiol. Plant Mol. Bioi. 39, 439-473. 
38 
Chapter 6 
Conclusion 
During a screening-based search for natural plant growth retardants, I found a fungus 
whose culture filtrate acted as a plant growth retardant. The fungus was identified as 
Peniophora nuda on the basis of electron microscopy observations and its ISS rRNA gene 
sequence. Three metabolites (1-3) with rice plant growth retardant activity were isolated from 
the culture filtrate. Compound 1 was definitively identified as being identical to the 
chlamydocin analogue repmted by Gupta et al. (1994). Compounds 2 and 3 were also 
chlamydocin analogues, and were first repmted as natural products. The bioassay data 
indicated that the hydroxyl at the C-9 of abo is not essential for the retardant activity, but the 
ketone function at the C-8 of abo is important. I attempted to confirm the impmtance of the 
ketone function at the C-8 of abo in 1 by preparing some derivatives and determining their 
activities. The results indicated that all of the compounds that have a chlamydocin framework 
need the oxygen atom at the C-8 position to exhibit their retardant activity. In the course of 
my research on the structure-activity relationship, I discovered a novel compound 8 that 
requires no oxygen atom at the C-8 position but requires a specific alkyl group chain length to 
show the activity. The shoots of rice seedlings treated with 8 were markedly curved, 
suggesting that the dwarfism induced by 8 was apparently different from that induced by 1. 
This phenomenon prompted me to clarify the mode of action of 1 and 8. For this purpose I 
investigated the levels of endogenous ABA and GA 1 in rice seedlings whose dwarfism was 
induced by 1 or 8. In the case of 1, the results revealed that an increase in the ABA level and a 
decrease in the GA1 level retarded growth. In the case of 8, the dramatic reduction of the GA 1 
level retarded growth. I also determined the HDAC inhibitory activity of these compounds, 
because chlamydocin is known to inhibit HDAC activity. The results showed that the 
alteration of endogenous hormonal levels was not caused by HDAC inhibition, although 1 and 
4-6 inhibited HDAC activity. There is an important and interesting question, which step in 
GA biosynthesis both 1 and 8 inhibit, that still remains to be solved. 
39 
Acknowledgement 
I would like to express my deep gratitude, and sincere appreciation to Professor Hiromitsu 
Nakajima of Tottori University for his encouragement, advice and support. I am heartily 
grateful to Hideaki Fujiyama of Tottori University, Yoshihisa Ozoe of Shimane University, 
Hiroshi Otani of Tottori University and Kenji Matsui of Ymaguchi University for their useful 
advice. I am also heartily grateful to Professor Koichi Yoneyama of Utsunomiya University 
and Research Associate Tamaki Honma of Tottori University for their valuable guidance. I am 
deeply indebted to Professor Takeshi Sassa of Yamagata University for his kind gift of GA1 
and Associate Professor Yukihiro Sugimoto of the Arid Land Research Center of Tottori 
University for his kind assistance in measuring the NMR. I wish to express my deep 
appreciation to late Professor Emeritus Takashi Hamasaki. Finally, I would like to thank all of 
my graduated and present members of our laboratory for their help. 
Summary 
In rice cultivation, the use of plant growth retardant to control plant height is very 
important to reduce lodging. During a screening of more than 300 soil fungi collected from 
Tottori Prefecture, Japan, for natural plant growth retardant, I found a fungus, whose culture 
filtrate could reduce the height of rice seedlings without causing either blotch or wilting. I 
identified the fungus as Peniophora nuda on the basis of electron microscopy observations 
and its 18S rRNA gene sequence. And from the culture filtrate, three active metabolites (1-3) 
were isolated. The structures of compounds 1-3 were characterized by spectral data and 
chemical conversion. Compound 1 was definitively identified as being identical to the 
chlamydocin analogue repmted by Gupta et al. (1994). Compounds 2 and 3 were also 
chlamydocin analogues and differ on the C9 of aod. They were the first isolation as natural 
products. I tested their plant growth retardant activities in a microdrop bioassay of rice ( cv. 
Koshihikari) seedlings. Administration of 10 nmol/plant of 1 or 2 reduced the second leaf 
sheath length of the treated plants, respectively to 73 and 71% of the value for the water 
control. The same amount of 3 reduced growth of the second leaf sheath to 83% in the treated 
as compared to control plants. This suggested that the hydroxyl at the C-9 of aho is not 
essential for the retardant activity, but the ketone function at the C-8 of aho is impmtant. Six 
derivatives from 1 and 2, and two synthetic analogues were prepared to investigate the 
structure-activity relationship of 1 more. These data revealed two types of retardant in 
chlamydocin analogues. One, for example in compound 1, requires the oxygen atom at C-8 of 
aod to exhibit the retardant activity. The other, for example in compound 8, requires no 
oxygen atom at the C-8 position but requires a specific alkyl group chain length to exhibit the 
activity. 
In order to understand the difference in the mode of action of these two types of retardant, 
the endogenous ABA and GA1 in the rice seedlings treated with them were analyzed by 
LC-MS and ELISA, respectively. Treatment with 1 (10 nmol/plant) increased the ABA level 
to 4 times higher than that of the control and decreased the GA1 level to 20% of that of the 
control. Treatment with 8 (30 nmol/plant) did not affect the ABA level but decreased GA 1 
content to 5% of that of the control. These results indicated that the increase in the ABA level 
and the decrease in the GA1 level caused growth retardation in the case of 1, and the dramatic 
reduction of the GA1 level caused it in the case of 8. I also determined the HDAC inhibition 
by their retardants by using HDACs from HeLa cells, because chlamydocin is known to 
inhibit HDAC. The inhibitory activity of 1 was almost same as trichostatin A at 10 nM. On 
the other hand, even a 10000 nM of 8 did not inhibit the HDAC. To understand the 
relationship between the plant growth retardation of 1 and HDAC inhibition, I tested the plant 
growth retardant activity of trichostatin A, and found that it did not have the retardant activity 
at the dose of 30 nmol/plant. These results showed that the inhibitory activity of HDAC was 
not linked to the plant growth retardant activity. 
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摘要
綾化剤はイネなどの倒伏軽減による増収を目的として用いられる。鳥取県内の土
壌から分離した糸状薗約 300種類の代謝産物中にイネ綾化物質を検索した。結果に
基づいて i種類の糸状菌を選抜し、電子顕微鏡による観察と 18SrRNA配列の相向
性から、担子薗類の Peniophoranudaと同定した。 P.nud，αを培養し、その培養憶液よ
り活性物質 1-3を得た。各種機器分析ならびに化学的誘導の結果、化合物 1は 1994
年に Guptaらが報告した chlamydocinの類縁化合物であることがわかった。化合物 2
と3もchlamydocinの類縁化合物であり、 2-アミノ-8-オキソデカン酸の C9位の置換
基だけが異なっていた。化合物 2と 3は新規化合物であった。点滴法を用いたイネ
生育試験において 1と2は 10nmol/plantの投与量で対照の 73%と71%までイネを媛
化させた。化合物 3は同じ投与量で対照の 83%までイネを媛化させた。化合物 1と
2で活性が変わらないことから、 2-アミノ-9-ヒドロキシ-8-オキソデカン酸の C9位の
水酸基は媛化活性に関与しないことがわかった。また C9位の罷換基が嵩高くなるこ
とで活性が弱まったことから、エアミノ-9-ヒドロキシω8オキソデカン酸の C8位の
ケトン基の重要性が示唆された。
この C8位のケトン基の重要性を調べるため、いくつかの化合物を調製または合成
し、イネ生育試験を行った。この結果、媛化には、ユアミノ-8-オキソデカン酸部分
の C8位の酸素原子もしくは特有の炭素鎖の長さが関わることがわかった。 C8イ立に
酸素原子を持つ化合物として 1を、特有の炭素鎖の長さを持つ化合物として 8を用
い、これらの作用機作を検討した。
化合物 1もしくは8をイネ幼鞘に与えた際の、地上部に含まれる ABAとGA]量を
調べた。 ABAについては抽出時にd6ABAを加え、 LC-MSにより同定、定量した。
GA]については GC-MSにより向定し、 ELISAで定量を行った。化合物 1を 10
nmol/plantずつ処理したイネの ABA含量は対照の 4倍に増加していた。また GA]含
量は対照の 20%に減少していた。これらのことから、化合物1による綾化現象はABA
の増加と GA]の減少により引き起こされていることがわかった。一方、化合物 8を
30 nmol/plantずつ処理したイネの ABA含量は対照と同じであった。また GA]含量は
対照の 5%に減少しており、化合物 8による嬢化現象は GA]の著しい減少により引
き起こされていることがわかった。
ChlamydocinはHDACを阻害することが知られている。そこで、得られた媛化物
質が註DACを阻害するかどうかを調べた。 HeLa細胞出来の HDACを用い、 HDAC
阻害剤として知られる trichostatinAと組害活性の強さを比較した。化合物 1は 10nM
でtrichostatinAと同程度の阻害活性を示した。一方、化合物 8は 10000nMでも阻害
活性を示さなかった。託DAC盟害と 1による楼化との関係を調べる為、 trichostatinA 
の倭化活性を調べたところ、 30nmol/ plantの投与量でも媛化作用を示さなかった。
従って HDAC阻害は媛化の藤因ではないことがわかった。
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